Primary total hip arthroplasty for primary osteoarthritis in Finland : a national register based analysis by Mäkelä, Keijo
Department of Orthopaedics and Traumatology
Helsinki University Central Hospital
University of Helsinki
Primary total hiP arthroPlasty for 
Primary osteoarthritis in finland 
– A nAtionAl register bAsed AnAlysis 
Keijo mäkelä
ACADemiC DisserTATiOn
To be presented, with the assent of the Faculty of medicine of  
the University of Helsinki, for public discussion in the Faltin room of  
the surgical Hospital, Kasarmikatu 11-13, at 12 noon, on may 12th, 2010. 
Helsinki 2010
Supervised by:
Docent Ville Remes MD, PhD
Department of Orthopaedics and Traumatology, Peijas, Helsinki University Central 
Hospital and
University of Helsinki, Finland
Antti Eskelinen MD, PhD 
Coxa Hospital for Joint Replacement and University of Tampere, Finland
Reviewed by:
Docent Teemu Moilanen MD, PhD
Coxa Hospital for Joint Replacement and University of Tampere, Finland
Docent Hannu Miettinen MD, PhD
Department of Orthopaedics and Traumatology, Kuopio University Hospital and 
the University of Eastern Finland 
Discussed with:
Professor Leif Havelin MD, PhD
The Norwegian Arthroplasty Register, Department of Orthopaedic Surgery, 
Haukeland University Hospital, Bergen, Norway and Department of Surgical 
Sciences, University of Bergen, Norway
ISBN 978-952-9657-50-6 (pbk.)
ISBN 978-952-9657-51-3 (PDF)
ISSN 1455-1330
Helsinki University Print
Helsinki 2010
3to Jill
4Contents
2. LIST OF ORIGINAL PUBLICATIONS .........................................................9
3. ABBREVIATIONS  .....................................................................................10
4. ABSTRACT  ......................................................................................11
5. INTRODUCTION  .....................................................................................14
6. REVIEW OF LITERATURE .......................................................................16
 6.1 Etiology of primary OA .........................................................................16
 6.1.1 Genetics  .....................................................................................16
 6.1.2 Age and gender .............................................................................. 17
 6.1.3 Moderate dysplasia ........................................................................18
 6.1.4 Femoroacetabular impingement ...................................................18
 6.1.5 Overweight  .....................................................................................19
 6.1.6 Heavy physical workloads ............................................................. 19
  6.1.6.1 Occupational activities ........................................................... 19
  6.1.6.2 Sports .................................................................................... 20
 6.2 Epidemiology of THA  ......................................................................... 20
 6.2.1 Women to men ratio ..................................................................... 20
 6.2.2 Average age ....................................................................................21
 6.2.3 Indications .....................................................................................21
 6.2.4 Incidence  .....................................................................................22
 6.3 Results of different THA fixation concepts ..........................................22
 6.3.1. Background of THA ......................................................................22
 6.3.2 Cemented THA ..............................................................................23
 6.3.3 Cementless THA ............................................................................24
 6.4 Regional variation in the incidence of THA ........................................29
 6.5 The effect of hospital volume on performance of THA ....................... 31
5 6.5.1 The length of stay and costs ........................................................... 31
 6.5.2 Unscheduled re-admissions  ......................................................... 31
 6.5.3. Mortality  .....................................................................................32
 6.5.4 Dislocations ...................................................................................33
 6.5.5 Infections  .....................................................................................33
 6.5.6 Re-operations ................................................................................34
7. AIMS OF THE PRESENT STUDY .............................................................35
8. PATIENTS AND METHODS .......................................................................36
 8.1 Patients  .....................................................................................36
 8.1.1 Finnish Arthroplasty Register-based studies (I, II and III) ..........36
 8.1.2 Hospital Discharge Register-based studies (IV and V) .................45
 8.2 Methods   .................................................................................... 48
 8.2.1 Finnish Arthroplasty Register-based studies (I, II and III) ......... 48
 8.2.2 Hospital Discharge Register-based studies (IV and V) ................49
 8.2.3 Statistical methods (I, II, III, IV, V) .............................................. 51
 8.2.4 Ethical considerations ...................................................................53
9. RESULTS   .....................................................................................54
 9.1 The Finnish Arthroplasty Register-based studies (I, II and III) .........54
 9.1.1 Femoral components ......................................................................54
 9.1.1.1 Stem groups, survival rate for aseptic loosening ........................54
 9.1.1.2 Cemented stems, survival rate for aseptic loosening .................54
 9.1.1.3 Cementless stems, survival rate for aseptic loosening ...............58
 9.1.2 Acetabular components .................................................................59
 9.1.2.1 Cup groups, survival rate for aseptic loosening ..........................59
 9.1.2.2 Cemented cups, survival rate for aseptic loosening ...................64
 9.1.2.3 Cementless cups, survival rate for aseptic loosening .................64
 9.1.3 Total hip replacements ................................................................. 68
 9.1.3.1 Total hip replacement groups .................................................... 68
6 9.1.3.1.1 Survival rate for aseptic loosening .......................................... 68
 9.1.3.1.2 Survival rate for any reason .....................................................69
 9.1.3.2 Cemented total hip replacements  ..............................................69
 9.1.3.2.1 Survival rate for aseptic loosening ...........................................69
 9.1.3.2.2 Survival rate for any reason .....................................................75
 9.1.3.3 Cementless total hip replacements  ............................................76
 9.1.3.3.1 Survival rate for aseptic loosening ...........................................76
 9.1.3.3.2 Survival rate for any reason .....................................................79
 9.2 Hospital Discharge Register-based studies (IV and V) ...................... 83
 9.2.1 Regional variation in THA rates (study IV).................................. 83
 9.2.2 Variables possibly associated with  
regional variation of THA (study IV) ................................................ 84
 9.2.3 LOS, LUIC and costs (study V) .................................................... 86
 9.2.4 Unscheduled re-admissions and complications (study V)  ......... 90
10. DISCUSSION  .....................................................................................91
 10.1 Validity of the data ..............................................................................91
 10.1.1 The Finnish Arthroplasty Register-based studies (I, II and III) . 91
 10.1.2 Hospital Discharge Register-based studies (IV and V) ...............92
 10.2 General discussion ..............................................................................93
 10.2.1 The Finnish Arthroplasty Register-based studies (I, II and III) .93
 10.2.1.1 Implant groups ..........................................................................93
 10.2.1.2 Cemented THA ..........................................................................94
 10.2.1.2.1 The Charnley prosthesis .........................................................94
 10.2.1.2.2 The Lubinus prosthesis ..........................................................95
 10.2.1.2.3 The Exeter prosthesis .............................................................95
 10.2.1.2.4 The Müller prosthesis ............................................................95
 10.2.1.2.5 The Elite Plus prosthesis ........................................................95
 10.2.1.2.6 The Spectron EF/the Reflection All-poly ..............................96
7 10.2.1.3 Cementless THA ........................................................................97
 10.2.1.3.1 The Biomet prostheses ...........................................................97
 10.2.1.3.2 The Anatomic Mesh/Harris-Galante II ................................ 98
 10.2.1.3.3 The PCA prosthesis ............................................................... 98
 10.2.1.3.4 The ABG prosthesis ............................................................... 98
 10.2.1.3.5 Patients aged 75 years or older ..............................................99
 10.2.2 Hospital Discharge Register-based studies (IV and V) ............100
 10.2.2.1 Regional variation in THA rates .............................................100
 10.2.2.2 Variables associated with regional variation of THA .............100
 10.2.2.2.1 Surgeon density and population density .............................100
 10.2.2.2.2 The ratio of primary THA for primary OA to  
primary THA for any reason ................................................. 101
 10.2.2.2.3 The need-adjusted expenses of specialized care ................. 101
 10.2.2.2.4 Proportion of working-aged patients having permanent 
disability pension because of orthopedic disorders ..............102
 10.2.2.2.5 Relative number of long-term illnesses ..............................102
 10.2.2.2.6 Socio-economic status .........................................................102
 10.2.2.3 The association of hospital volume with results of THA .......103
 10.2.2.3.1 LOS and costs .......................................................................103
 10.2.2.3.2 Unscheduled re-admissions ................................................103
 10.2.2.3.3 Dislocations .........................................................................103
 10.2.2.3.4 Infections .............................................................................104
 10.2.2.3.5 Re-operations ......................................................................104
11. CONCLUSIONS   ...................................................................................105
12. ACKNOWLEDGEMENTS ........................................................................107
13. REFERENCES   ...................................................................................109
8
92. list of oriGinal PUBliCations
The present thesis is based on the following original papers, which will be referred 
to in the text by their Roman numerals:
I Mäkelä KT, Eskelinen A, Pulkkinen P, Paavolainen P, Remes V. Total hip 
arthroplasty for primary osteoarthritis in patients fifty-five years of age or older. 
An analysis of the Finnish Arthroplasty Registry. J Bone Joint Surg Am 2008; 
90: 2160-70.
II Mäkelä K, Eskelinen A, Pulkkinen P, Paavolainen P, Remes V. Cemented total 
hip arthroplasty for primary osteoarthritis in patients 55 years or over – Results 
of the 12 most common cemented implants followed for 25 years in the Finnish 
Arthroplasty Register.  J Bone Joint Surg Br 2008; 90: 1562-9.
III Mäkelä KT, Eskelinen A, Pulkkinen P, Paavolainen P, Remes V. Cementless 
total hip arthroplasty for primary osteoarthritis in patients aged 55 years old or 
over – results of the 8 most common cementless designs compared to cemented 
reference implants in the Finnish Arthroplasty Register. Acta Orthop 2010; 81: 
42-52.
IV Mäkelä KT, Peltola M, Häkkinen U, Remes V. Geographical variation in 
incidence of primary total hip arthroplasty: a population-based analysis of 
34,642 replacements. Arch Orthop Trauma Surg 2009; Jun 24. [Epub ahead 
of print].
V Mäkelä KT, Häkkinen U, Peltola M, Linna M, Kröger H, Remes V. The effect of 
hospital volume on length of stay, re-admissions and complications of total hip 
artrhoplasty in Finland – a population-based register analysis of 81 hospitals 
and 28,218 replacements. Submitted.
10
Primary total hip arthroplasty for primary osteoarthritis in Finland
3. aBBreViations
AOA  Australian Orthopaedic Association
ASA  American Society of Anesthesiologists 
CI  confidence interval
DDH   developmental dysplasia of the hip
DHR  the Danish Hip Arthroplasty Register
HA  hydroxyapatite
HHS  Harris Hip Score
ICD  International Classification of Diseases
LOS  length of stay
LUIC  length of uninterrupted institutional care
NAR  the Norwegian Arthroplasty Register
NICE  National Institute for Clinical Excellance
NOMESCO the Nordic Medico-Statistical Committee
OA  osteoarthritis
OECD  Organisation for Economic Co-operation and Development
OR  odds ratio
RA  rheumatoid arthritis
RR  risk ratio
SHAR  the Swedish Hip Arthroplasty Register
THA  total hip artrhroplasty
THR  total hip replacement
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4. aBstraCt
Introduction
Promising results on the performance of cementless implants for patients under 
55 years of age have been obtained. As to whether the survival of cementless total 
hip replacements is as good as that of cemented total hip replacements for those 
patients aged 55 years and older has been investigated in this study.
Considerable variation in THA incidence between regions has been described. 
Suggested reasons for this variation include inter alia socio-economic factors and the 
number of surgeons in any particular region. Hospital volume is a known indicator 
of orthopaedic adverse events in patients undergoing THA. In systematic literature 
reviews, an association was found between higher hospital volumes and lower rates 
of mortality and hip dislocation.
Aims of the present study
The first aim was to evaluate the survival of THA in patients aged 55 years and older 
at the time of the primary operation on a nation-wide level. The second aim was 
to evaluate, on a nation wide-basis, the geographical variation of the incidence of 
primary THA for primary OA and also to identify those variables that are possibly 
associated with this variation. The third aim was to evaluate the effects of hospital 
volume: on the length of stay, on the numbers of re-admissions and on the numbers 
of complications of THR on population-based level in Finland.
Methods
1) From 1980 to 2004 inclusive, a total of 50,968 primary THRs that met our criteria 
were entered in the Finnish Arthroplasty Register. The survival rate of different 
implant groups was analysed.
2) Between 1980 and 2005 inclusive, a total of 41,034 primary cemented THAs 
performed for primary osteoarthritis in patients aged 55 years and over were entered 
in the Finnish Arthroplasty Register. The 12 most commonly used cemented total hip 
replacements (cup + stem combinations), which accounted for 84% (34,549) of all 
cemented replacements performed for primary OA, were subjected to survival analyses.
12
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3) Inclusion criteria permitted 10,310 cementless replacements (8 designs) 
performed on patients aged 55 years or older to be selected for evaluation. The 
risk of revision for each of the 8 implants were compared with that of a group 
comprising three cemented designs as the reference (9,549 replacements).
4) Using Hospital Discharge Register, 34,642 THAs performed for primary OA 
over the 1998 to 2005 period were identified. The adjusted incidence indices for 21 
hospital administrative regions were determined. Logistic regression analyses and 
generalized linear models were used for studying the association between potential 
explanatory factors with the variation in the incidence of THA.
5) Using the information from the Hospital Discharge Register, 28,218 THRs 
performed for primary osteoarthritis over the 1998 and 2005 period were identified. 
Hospitals were classified into four groups according to the number of THRs 
performed on an annual basis over the whole study period: 1-50 (Group 1), 51-
150 (Group 2), 151-300 (Group 3) and 301 or over (Group 4). Logistic regression 
analyses and generalized linear models were used to study the effect of hospital 
volume: on length of stay, on unscheduled re-admissions and on re-operation, 
dislocation and infection rates.
Results
1) Cementless THRs had a significantly reduced risk of revision for aseptic loosening 
compared with cemented hip replacements (p < 0.001). When revision for any reason 
was the end point in the survival analyses, there were no significant differences 
found between the groups.
2) Only two designs of femoral component, the Exeter Universal (Stryker 
Howmedica, Mahwah, New Jersey, USA) and the Müller Straight (Zimmer, Warsaw, 
Indiana, USA) had a survivorship of over 95% at 10 years with revision for aseptic 
loosening as the endpoint.
3) In all patients aged 55 years or more, the Bi-Metric stem had a higher survival 
rate for aseptic loosening at 15 years follow-up than the cemented reference group 
[96% (95% CI 94-98) vs. 91% (CI 90-92)].
4) Adjusted incidence ratios of THA varied from 1.9- to 3.0-fold during the study 
period. When the ratio of THAs performed for primary OA to THAs performed for 
any reason was high, the absolute incidence of THAs was high (p<0.001). Neither 
the average income within a region nor the morbidity index was associated with 
the incidence of THA.
5) For the four categories of volume of THR performed per hospital, the length 
of the surgical treatment period was shorter for the highest volume group (Group 4) 
than for the lowest volume group (Group 1) (p<0.0001). The odds ratio for dislocations 
(0.70, 95% CI 0.55-0.90) was significantly lower in the Group 3, than in the Group 1.
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Conclusions
1) In patients who were 55 years of age or older, the long-term survival of cementless 
total hip replacements was as good as that of the cemented replacements. However, 
multiple wear-related revisions of the cementless cups indicate that excessive 
polyethylene wear was a major clinical problem with modular cementless cups 
for all age groups.
2) The variation in the long-term rates of survival for different cemented stems 
was considerable for patients aged 55 years or older. 
3) Cementless proximal porous-coated stems were found to be a good option for 
elderly patients. Even though biological fixation is a reliable fixation method of THA, 
polyethylene wear and osteolysis remain a serious problem for cementless cups. 
4) When hip surgery was performed on with a large repertoire, the indications to 
perform THAs due to primary OA were tight. Socio-economic status of the patient 
had no apparent effect on THA rate. 
5) Specialization of hip replacements in high volume hospitals should reduce costs 
by significantly shortening the length of stay, and may reduce the dislocation rate.
14
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5. introdUCtion
This study was performed to analyse if cementless fixation of THA is as durable as 
cement fixation in patiets aged 55 years and older. It was also performed to analyse 
surgeon and hospital volume related parameters in THA. It was not the aim of the 
study to analyse hip resurfacing arthroplasty, which has become popular in recent 
years, or bearing couples of the prostheses. Long term bearing couples data are not 
available from the Finnish Arthroplasty Register. 
Total hip arthroplasty (THA) is the golden standard of treatment for severe 
osteoarthritis (OA) of the hip refractory for conservative treatment. Cemented low-
friction arthroplasty, which was pioneered by Sir John Charnley (Charnley 1960, 
Charnley 1961) is largely the basis of the modern THA. Cemented Charnley prosthesis 
(Johnson & Johnson, New Brunswick, New Jersey, USA) is still considered as the 
gold standard for total hip arthroplasty, against which all new implants should be 
compared. A 10-year survival rate of 90 per cent or more (National Institute for 
Clinical Excellance, NICE) is considered a good long-term outcome. The 25-year 
survival rate of 80 per cent of the Charnley prosthesis has remained unsurpassed 
(Callaghan et al. 2000, Berry et al. 2002, Wroblewski et al. 2002, Della Valle et al. 
2004a, Buckwalter et al. 2006, Morshed et al. 2007). A good long-term outcome 
has also been recorded with other cemented implants (Havinga et al. 2001, Räber 
et al. 2001, Williams et al. 2002, Kale et al. 2003, Carrington et al. 2009, Clauss et 
al. 2009). However, most of these studies refer to only one total hip replacement 
design performed in a single center. In the Nordic countries national registers were 
established: for Sweden in 1979, for Finland in 1980, for Norway in 1987 and for 
Denmark in 1995, to evaluate the population-based results of THA. Data based on 
Nordic arthroplasty registers have shown that the survival of cemented implants 
for elderly and sedentary patients with primary osteoarthritis is high (Havelin et 
al. 2000, Havelin et al. 2002, Malchau et al. 2002, SHAR 2007, Havelin et al. 
2009). The use of cemented implants in Finland is not as common as that found in 
Sweden and in Norway, and the results have not been as flattering (Puolakka et al. 
2001a). Further, in patients under the age of 55 years in Finland, the population-
based survival of cementless proximal porous coated stems was even better than 
the survival of cemented stems (Eskelinen et al. 2005, Eskelinen et al. 2006). High 
survival rates have also been found for cementless stems as based on data from the 
Norwegian Arthroplasty Register (Havelin et al. 2000, Hallan et al. 2007). However, 
due to excessive wear of the polyethylene liner, survival of modular cementless cups 
has not been as good as that of cemented cups (Havelin et al. 2000, Malchau et al. 
2002, SHAR 2007, Havelin et al. 2009).
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Variation in surgery rates within a single country have already been reported 
in several studies published during the 1970s and 1980s (McPherson et al. 1982, 
Wennberg et al. 1982, Chassin et al. 1986). The incidence ratio of THA has been 
shown to vary from 1.25 to 4.7 between regions of the same country (Keskimäki et 
al. 1994, Birkmeyer et al. 1998, Pedersen et al. 2005, Dixon et al. 2006). Several 
studies have examined explanatory variables related to regional variation of THA 
including: population density, surgeon density, socio-economic factors, and surgeon 
enthusiasm (Keller et al. 1990, Peterson et al. 1992, Baron et al. 1996, Keskimäki et 
al. 1996, Wright et al. 1999, Söderman et al. 2000, Hawker et al. 2002, Hudak et 
al. 2002, Mahomed et al. 2003, Skinner et al. 2003, Milner et al. 2004, Pedersen 
et al. 2005, Dixon et al. 2006). 
The association of hospital volume with the results of total hip replacements 
(THR) has been investigated in several studies (Lavernia et al. 1995, Espehaug 
et al. 1999, Katz et al. 2001, Solomon et al. 2002, Doro et al. 2006, Battaglia et 
al. 2006, Shervin et al. 2007). It has been suggested, that surgeon volume and 
hospital volume are the best indicators of orthopaedic adverse events in patients 
undergoing THR surgery (Solomon et al. 2002). Lower provider volume has been 
associated with longer hospital stay after THR surgery (Doro et al. 2006, Judge 
et al. 2006) and also with higher costs (Kreder et al. 1997, Martineau et al. 2005, 
Mitsuyasu et al. 2006). 
16
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6. reVieW of literatUre
6.1 etiology of primAry oA
Osteoarthritis of the hip can result from several different patterns of joint failure. 
Underlying pathological changes due to conditions including: osteonecrosis, trauma, 
sepsis, Paget’s disease and rheumatoid arthritis can result in degeneration of the 
joint. Anatomical abnormalities such as DDH or slipped capital femoral epiphysis 
can result in osteoarthritic changes. In 70-90 per cent of patients undergoing THA 
in Nordic countries, neither an anatomical abnormality nor any specific disease 
can be identified (Rantanen et al. 2006, SHAR 2007, DHR 2008, NAR 2008, 
AOA 2009). This condition is called primary OA of a hip and the diagnosis of it is 
performed by the exclusion of other causes.
6.1.1 genetics
It has been proved that primary OA of the hip is strongly genetically determined, 
with an estimated heritability in excess of 50 per cent (Spector et al. 1996, Chitnavis 
et al. 1997). Twin-pair, sibling-risk and segregation studies have revealed a major 
genetic component that is transmitted in a nonmendelian manner. OA therefore 
fits best into the complex, multifactorial class of common diseases (Loughlin 2005). 
Ingvarsson et al. (2000) combined two Icelandic population-based databases: 
a national register of THRs and a genealogy database of all available Icelandic 
genealogy records for the last 11 centuries. A large number of familial clusters of 
patients with THR for OA were identified. Icelandic OA patients with THR were 
significantly more closely related to each other than matched controls drawn from 
the general Icelandic population. Bukulmez et al. (2006) compared the prevalence 
of arthroplasty for idiopathic hip OA among siblings of the patients with that of the 
prevalence among the siblings of the patients’ spouses. Familial aggregation for THA 
was observed after controlling for age and sex, which suggests a genetic contribution 
to end-stage hip OA. Chitnavis et al. (1997) have found that the relative risk for 
having THR in the patients’ siblings was 1.86 that found for their spouses. Lanyon 
et al. (2000) found that the age-adjusted odds ratios in THR patients’ siblings was 
6.4 that obtained for the control group for hip OA. Lanyon et al. (2004) conducted 
a sibling study, in which at least one sibling of a family had undergone THR. These 
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authors found that the age adjusted odds ratios for hip OA were twofold higher 
in siblings of index THR patients who had no osteophyte response than that of 
their corresponding siblings whose index case had osteophytes. They concluded 
that careful phenotypic characterisation is essential for genetic studies of hip OA.
Osteoarthritis of the hip can occur as part of a generalized process (Croft et al. 
1992a, Hochberg et al. 1995, Dahaghin et al. 2005). Susceptibility genes for OA 
can be identified with association studies (Ikegawa 2007). For example, replication 
studies have confirmed the association of functional sequence variations in the 
secreted frizzled-related protein-3 and asporin genes with the occurrence of OA. 
Recent studies have also prompted discussion of population-spesific differences in 
reported associations (Ikegava 2007). A meta-analysis of the association between 
aspartatic acid (D)-repeat polymorphism in the gene encoding asporin and OA 
found a positive association between knee OA and the D14 allele with non-significant 
heterogeneity. In hip OA significant heterogeneity was identified and there was no 
positive association for any allele in any comparison. It was concluded that though 
the association of the asporin D 14 allele and knee OA has global relevance, its effect 
has ethnically associated differences (Nakamura et al. 2007).
Significant differences in the underlying prevalence of hip OA between 
populations have been reported (Lohmander et al. 2006). OA accounted for a 
greater percentage among whites as an indication for THR (59% for women and 
66% for men) than among Japanese (36% of women and 30% of men) (Oishi et 
al. 1998). In a population-based study in San Francisco conducted by Hoaglund 
et al. (1995), a primary OA diagnosis in patients having THA was the greatest 
among white subjects (66%), followed by black subjects (54%), Hispanics (53%) 
and Asians (28%). The mean age of patients undergoing THR for primary OA was 
70 years for white subjects and almost 10 years less for all other groups. Nevitt et 
al. (2002) found that hip OA was 80-90 per cent less frequent in Beijing, China 
than in white persons in the US. 
6.1.2 Age And gender
Epidemiological studies have documented that aging is a major risk factor for OA of 
the hip (Havelin et al. 1993, Corti and Rigon 2003, D’Ambrosia 2005, Andrianakos et 
al. 2006). Although the incidence of OA before the age of 50 is lower among women 
than among men, it increases progressively in women after the menopause, and 
remains relatively unaltered among men after the fifth decade of life (Oliveria et al. 
1995). This suggests that a decrease in gonadal steroids in post-menopausal women 
play a role in the development of OA (Oliveria et al. 1996). In asymptomatic subjects 
Lanyon et al. (2003) found that minimum hip joint space width progressively 
18
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decreased in post-menopausal women, whereas it remained relatively unaltered 
in men throughout life. Jacobsen and Sonne-Holm (2005) also found a progressive 
decrease in mean minimum hip joint space width after the fifth decade of life in 
females but no such decrease in male.
6.1.3 moderAte dysplAsiA
Hip dysplasia is a well-known pre-osteoarthritic condition leading to premature 
radiological OA of the hip. The extent and rate at which degeneration develops 
in moderately dysplastic hips, however, is not defined. Jacobsen et al. (2005) 
investigated relationship between hip dysplasia and OA by analysing standardized 
pelvic radiographs and found a prevalence of hip dysplasia of 3.4 per cent. Mild 
to moderate hip dysplasia was not an unusual condition in the population; 
prevalences range from 3.5 per cent to 10.7 per cent depending on the index used. 
There were significant relationships between radiographic OA discriminators and 
the radiographic parameters of hip dysplasia. Moreover, in a study carried out by 
Jacobsen and Sonne-Holm (2005), hip dysplasia was reported to be associated with 
the development of hip OA. In a systematic review of the literature by Lievense 
et al. (2004), six out of nine studies reported a positive association between hip 
dysplasia and hip OA (Murray 1965, Wedge et al. 1991, Hasegawa 1994, Murphy 
et al. 1995, Laforgia et al. 1996, Lane et al. 2000). The only prospective follow up 
study reported that patients with dysplasia had a 2.8 higher risk of developing hip 
OA (Lane et al. 2000). Three studies reported either a negative or no association 
(Terjesen et al. 1982, Lau et al. 1995, Yoshimura et al. 1998). In a study conducted 
by Chitnavis et al. (2000), up to 40 per cent of hips of patients undergoing THR 
manifested acetabular dysplasia and a further 10 per cent possibly had previously 
slipped upper femoral epiphyses.
6.1.4 femoroAcetAbulAr impingement
Evidence is emerging that subtle morphologic abnormalities around the hip result in 
femoroacetabular impingement and may be a contributing factor to OA (Ganz et al. 
2003, Beck et al. 2005, Parvizi et al. 2007a, Tannast et al. 2008). The morphologic 
abnormalities result in abnormal contact between the femoral neck/head and the 
acetabular margin, which causes tearing of the labrum and avulsion of the underlying 
cartilage region, continued deterioration and eventual onset of arthritis (Parvizi et 
al. 2007a). The most frequent location for femoroacetabular impingement is the 
anterosuperior rim area. The most critical motion is the internal rotation of the 
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hip at 90 degrees flexion. Two types of femoroacetabular impingement have been 
identified. Cam-type femoroacetabular impingement, which is more prevalent in 
young male patients, is caused by an offset pathomorphology between the head 
and neck and produces an outside-in delamination of the acetabulum. Pincer-type 
femoroacetabular impingement is more prevalent in middle-aged women and is 
produced by a more linear impact between a local (retroversion of the acetabulum) 
or general overcoverage (coxa profunda/protrusio) of the acetabulum. The damage 
pattern of pincer-type impingement is more restricted to the rim than that of the 
cam-type, and the process of joint degeneration is slower. Most hips, however, show 
a mixed femoroacetabular impingement pattern with cam predominance (Ganz et 
al. 2008). In the study conducted by Gosvig et al. (2008), the overall prevalence of 
cam deformity was found to be approximately 17 per cent in men and 4 per cent in 
women. It was hypothesized that the preosteoarthritic cam deformity may represent 
a silent slipped capital epiphysis especially in men.
6.1.5 overweight
An association between being overweight and hip OA has not been thought to be 
as important as it is in knee OA. However, in a systematic review of literature of 12 
studies (Saville and Dickson 1968, Kraus et al. 1978, Hartz et al. 1986, van Saase et al. 
1988, Heliovaara et al. 1993b, Tepper and Hochberg 1993, Olsen et al. 1994, Roach 
et al. 1994, Vingård et al. 1997a, Cooper et al. 1998, Gelber et al. 1999, Oliveria et al. 
1999) on the influence of obesity on the developement of OA of the hip, Lievense 
et al. (2002) found moderate evidence for a positive association between obesity 
and the occurrence of the hip OA, with an odds ratio of approximately two. In later 
studies conducted by Flugsrud et al. (2002), Karlson et al. (2003), Flugsrud et al. 
(2006), Harms et al. (2007) and Liu et al. (2007) associations between higher BMI 
and an increased risk of THR and also between higher BMI and hip OA were found 
(Järvholm et al. 2005). However, in a study by Reijman et al. (2007) a high BMI 
at baseline was reported not to be associated with the incidence and progression 
of hip OA.
6.1.6 heAvy physicAl workloAds
6.1.6.1 Occupational activities
The possible causal relationship between heavy physical workloads over prolonged 
periods of time and the development of hip OA has been the focus of several studies. 
Lievense et al. (2001) reviewed 16 studies (Partridge and Duthie 1968, Lindberg 
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and Danielsson 1984, Jacobsson et al. 1987, Thelin 1990, Vingård et al. 1991, Croft 
et al. 1992b, Croft et al. 1992c, Vingård et al. 1992, Heliövaara et al. 1993b, White 
et al. 1993, Olsen et al. 1994, Roach et al. 1994, Thelin et al. 1997, Vingård et al. 
1997b, Coggon et al. 1998, Yoshimura et al. 2000) and found moderate evidence for 
a positive association, with an odds ratio of approximately three, between previous 
heavy physical workload and the occurrence of hip OA. All the 16 studies reviewed 
revealed a positive association between physical workload and hip OA. In a study of 
Rossignol et al. (2005), occupations with the greatest prevalence rate ratio for hip, 
knee and hand OA were: female cleaners (6.2), women in the clothing industry (5.0), 
male masons and other construction workers (2.9), in addition to male and female 
workers in agriculture (2.8). Early onset of OA was seen in the more heavy labour 
jobs with almost 40 per cent of patients reporting their first symptoms before the 
age of 50. Thelin and Holmberg (2007) concluded that farmers had a significantly 
increased risk of OA of the hip as compared with their urban reference counterparts.
6.1.6.2 Sports
Lievense et al. (2003) reviewed 22 studies (Puranen et al. 1975, Kraus et al. 1978, 
Eastmond et al. 1979, Klünder et al. 1980, Sohn and Micheli 1985, Panush et al. 
1986, Andersson et al. 1989, Jucker 1990, Konradsen et al. 1990, Marti and Knobloch 
1991, Lindberg et al. 1993, Vingård et al. 1993, Kujala et al. 1994, van Dijk et al. 
1995, Vingård et al. 1995, Spector et al. 1996, Cooper et al. 1998, Lane et al. 1998, 
Vingård et al. 1998, Kujala et al. 1999, Lane et al. 1999, Kettunen et al. 2000) to 
provide updated data on the relation between sporting activities and the occurrence 
of the hip OA. It was concluded that there is moderate evidence for a positive 
association between hip OA and sporting activities in general, with an odds ratio 
of approximately two. However, no high-quality cohort studies were available for 
the best evidence synthesis, so the analysis was based on retrospective studies only. 
In a later study made by Schmitt et al. (2004), competitive sports were found to 
entail a high risk of hip arthrosis.
6.2 epidemiology of thA 
6.2.1 women to men rAtio
Women are more likely than men to suffer from osteoarthritis (O’Connor 2007). 
Therefore, more than 50 per cent of patients undergoing THA in Nordic countries 
are women (Lohmander et al. 2006). The mean ratios of women to men for the 
incidence of primary THR for primary OA in the 1996-2000 period were: 1.12 
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in Denmark, 1.15 in Finland, 1.29 in Iceland, 2.03 in Norway and 1.17 in Sweden 
(Lohmander et al. 2006). Females accounted for 58 per cent of the primary THA 
patients in Denmark, 60 per cent in Sweden, and 70 per cent in Norway during 
the 1995-2006 period, when all diagnoses were included (Havelin et al. 2009). In 
Australia, 55 per cent of patients with primary THR were women from year 1999 
to 2009 (AOA 2009).
6.2.2 AverAge Age
The average age of patients undergoing THA is slightly higher for women than 
for men. The mean age of patients was 68 years in Finland in 2005. In Sweden, 
the mean age was 67 years for men and 70 years for women during last 10 years 
(SHAR 2007). In Denmark, the mean age was 70 years for women and 66 years 
for men in 2007 (DHR 2008). In Australia, the mean age for primary THRs from 
1999 to 2009 was 67 years (69 years for women, 65 years for men) (AOA 2009). 
The mean age of the patients in Norway at the time of THA was 70 years for the 
1987-2006 period (NAR 2007). 
6.2.3 indicAtions
Primary OA is the most common indication for THA in Nordic countries. In 2004, 
76 per cent of THAs were performed for primary OA in Finland (Rantanen et al. 
2006). In 2007, 75 per cent of THAs were performed for primary OA in Norway, 
7 per cent for late sequelae from fracture of proximal femur and 7 per cent for 
sequelae from dysplasia (NAR 2008). In 2007, 83 per cent of THAs were performed 
for primary OA in Sweden, 10 per cent for fracture and 2 per cent for avascular 
necrosis. However, for patients under 50 years, only 57 per cent of THAs were 
performed for primary OA during 1992-2007 (SHAR 2007). In 2007, 78 per cent 
of THRs were performed for primary OA in Denmark, 7 per cent for late sequelae 
from fracture of proximal femur and 6 per cent for fresh fractures of the proximal 
femur (DHR 2008). In Australia, 89 per cent of THRs were performed for primary 
OA, 4 per cent were for avascular necrosis and 3 per cent for a fractured neck of 
the femur during 1999-2009 (AOA 2009). However, significant differences in the 
underlying prevalence of hip OA between different populations have been reported 
(Lohmander et al. 2006).
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6.2.4 incidence
The incidence rate per year per 100 000 of primary THR for primary OA increased 
from 68 to 80 in Denmark, from 71 to 77 in Finland, from 76 to 93 in Norway and 
from 86 to 99 in Sweden between the years 1996 to 2000 (Lohmander et al. 2006). 
The number of hip arthroplasties will further increase because 75 per cent of THAs 
are performed on patients of 60 years of age and older. However, the age-adjusted 
incidence of osteoarthrosis is not increasing (Danielsson and Lindberg 1997). In 
Norway, the overall incidence per 100,000 of the population was 152 primary total 
hip replacements in 2003 (NAR 2007). In Australia, the incidence of THR for any 
reason was 102 per 100 000 for the 2005-2006 period (AOA 2007).
6.3 results of different thA fixAtion concepts
6.3.1. bAckground of thA
Cemented low-friction arthroplasty was pioneered by Sir John Charnley (Charnley 
1960, Charnley 1961) who largely laid the basis of modern total hip arthroplasty. 
However, the problem of aseptic loosening of cemented implants soon emerged. 
Harris et al. (1976) reported extensive non-linear osteolysis in the proximal femur 
after cemented THA. This phenomenon was believed to be due to “cement disease”, 
and poor results of cemented THAs were considered to be associated with the use of 
bone cement. Thus, cementless THAs were developed as a solution to this problem. 
Some of first reports on cementless THAs were encouraging (Lord and Bancel 1983). 
However, the high failure rate of smooth threaded cups due to aseptic loosening 
soon became obvious (Engh et al. 1990, Tallroth et al. 1993, Simank et al. 1997). 
Porous surfaced cementless cups had better resistance to early aseptic loosening 
than smooth threaded cups (Engh et al. 1990), but polyethylene wear and osteolysis 
remained a problem (Barrack et al. 1997, Malchau et al.1997, Puolakka et al. 1999, 
Puolakka et al. 2001b, Havelin et al. 2002, Young et al. 2002, Duffy et al. 2004, 
von Schewelov et al. 2004). Promising short- to mid-term results of cementless 
THAs with highly cross-linked polyethylene bearings have recently been published 
(McCalden et al. 2009, Fukui et al. 2010). However, longer follow-up of cementless 
replacements with alternative bearings (highly cross-linked polyethylene, ceramic-
on-ceramic, metal-on-metal) is needed. Long term bearing couples data are not 
available from the Finnish Arthroplasty Register. Resurfacing hip arthroplasties 
have been performed for relatively young patients during last ten years in Finland. 
It was not the aim of the current study to analyse hip resurfacing arthroplasty.
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6.3.2 cemented thA
Minimum 25-year survival rates for aseptic loosening of cemented all-polyethylene 
cups in patients with no special attention to age ranged between 85-92 per cent for 
single centre studies (Callaghan et al. 2000, Della Valle et al. 2004a). However, the 
number of reports on the long term results of cemented cups is low compared to 
those studies on cemented stems. The long term survival of metal-backed cemented 
cups was found to be poor (Williams et al. 2002, Hook et al. 2006).
Minimum 25-year survival rates for aseptic loosening of cemented stems in 
patients of undefined age was 93 per cent (Callaghan et al. 2000) compared with 85 
per cent for any reason (Berry et al. 2002). Minimum 10- to 15 -year survival rates 
have been found to vary between 83-100 per cent for aseptic loosening (Havinga et 
al. 2001, Räber et al. 2001, Sanchez-Sotelo et al. 2002, Williams et al. 2002, Issack 
et al. 2003, Hook et al. 2006, Hauptfleisch et al. 2006, Riede et al. 2007, Callaghan 
et al. 2008, Clauss et al. 2009, Carrington et al. 2009) compared with 78-98 per 
cent for any reason (Alho et al. 2000, Annaratone et al. 2000, Sanchez-Sotelo et al. 
2002, Issack et al. 2003, Hook et al. 2006, Clauss et al. 2009, Carrington et al. 2009).
The long-term results of cemented THA are presented in Table 1. The focus of 
this review is mainly restricted to those studies for which the main diagnosis was 
primary osteoarthritis and the average patient age was 50 years or older.
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6.3.3 cementless thA
Minimum 15-year survival rates for cementless porous-coated cups in patients of various 
ages varied between 77-99 per cent for aseptic loosening (Bojescul et al. 2003, Della 
Valle et al. 2004b, Kim 2005, Anseth et al. 2009). Minimum 10-year survival rates for 
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aseptic loosening of the same kind of implants has been reported to vary between 92-
99 per cent (Archibeck et al. 2001, Meding et al. 2004, Parvizi et al. 2004b, Berli et al. 
2007, Firestone et al. 2007, Garcia-Rey et al. 2009). There are also reports of threaded 
cups with roughblasted outer surfaces that give better results than smooth threaded 
cups (Pieringer et al. 2003, Pospichill and Knahr 2005, Vervest et al. 2005, Pieringer 
et al. 2006, Zwartele et al. 2007). On the other hand, some HA-coated grit-blasted 
press-fit cups have poor survivorship (Kim et al. 2006, Reikerås and Gunderson 2006).
Minimum 10-year survival rate for cementless cups for any reason varies between 
81-100 per cent with osteolysis rates between 4-56 per cent (Xenos et al. 1999, Reitman 
et al. 2003, Gaffey et al. 2004, Oosterbos et al. 2004, Meding et al. 2004, Moskal et al. 
2004, Parvizi et al. 2004b, Pieringer et al. 2006, Röhrl et al. 2006, Berli et al. 2007). 
There are also numerous reports of catastrophic failure rates due to poor polyethylene 
liner wear resistance and osteolysis (Malchau et al. 1997, Puolakka et al. 2001b, von 
Schewelov et al. 2004, Hallan et al. 2006).
Minimum 15-year survival rate for cementless stems in patients with no special 
attention to age has varied between 83 and 98 per cent for aseptic loosening (Teloken 
et al. 2002, Bojescul et al. 2003, Grant and Nordsletten 2004, Kim 2005, de Aragon 
and Keisu 2007, Anseth et al. 2009), and also for any reason (Rajaratnam et al. 2008). 
The minimum 10-year survival rate has varied between 82 and 100 per cent (Xenos 
et al. 1999, Archibeck et al. 2001, Aldinger et al. 2003, Reitman et al. 2003, Berend 
et al. 2004, Meding et al. 2004, Parvizi et al. 2004a, Pospischill and Knahr 2005, 
Vervest et al. 2005, Pieringer et al. 2006, Surdam et al. 2007, Zwartele et al. 2007, 
Garcia-Rey et al. 2009).
There are several reports that focused on elderly patients who had undergone 
cementless THA. McAuley et al. (1998) reported on 196 cementless THRs in patients 
65 years and older (mean age 71 years, range 65-87). At a minimum five-year follow-
up (average 8 years) the re-operation rate was 4 per cent (7 hips). In a study of Purtill 
et al. (2001), the mean five-year survival (range 2-11 years) of 123 cementless stems in 
octogenarians (mean age 83 years) was 100 per cent. In a study of Keisu et al. (2001), 
the 2-11 year survival rate for aseptic loosening of 92 cementless THAs in patients of 
80-89 years of age was 100 per cent. Reitman et al. (2003) reported on 72 hips of 
patients whose mean age was 70 years (minimum 65 years). In a minimum 10 year 
follow-up the survival for any reason was 92 per cent for the cup and 99 per cent for the 
stem. In a study of Pieringer et al. (2003), the three to seven year survival for aseptic 
loosening of 48 cementless THAs in patients of 80-91 years of age was 100 per cent. 
Berend et al. (2004) reported on 49 hips with a cementless stem in patients with mean 
age of 79 years. These authors reported 100 per cent survival of the stem for aseptic 
loosening in 0.5-5.5 years follow-up.
The mid- and long-term results of cementless THA are presented in Table 2. The 
focus of this review is on studies for which the main diagnosis was primary OA and 
the average patient age 50 years or older. 
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In conclusion, polyethylene wear and periprosthetic osteolysis are the main problem 
of the cementless THA. Survival of cementless stems is excellent and does not 
depend on the patient’s age. More wear-resistant articulations for cementless 
cups are needed. Whether hard-on-hard articulations and highly cross-linked 
polyethylene will improve the results of cementless cups is still unknown. Laboratory 
data indicate greatly reduced wear rates for these new bearing couples (Clarke et 
al. 2000, Goldsmith et al. 2000, Shishido et al. 2003, Oonishi et al. 2004, Affatato 
et al. 2005, Dumbleton et al. 2006), but only short-term clinical data is available 
as yet (Dorr et al. 2000, Long et al. 2004, Seyler et al. 2006, Vassan et al. 2007).
6.4 regionAl vAriAtion in the incidence of thA
Regional variations in surgery rates were described in several studies as early as 
the 1970s and 1980s (McPherson et al. 1982, Wennberg et al. 1982, Chassin et al 
1986, Keskimäki et al. 1994). Procedures with unproven effectiveness and those 
performed for clinical conditions with multiple reasonable treatment options, 
including: coronary artery disease, prostate cancer or osteoarthritis, are most 
commonly subjected to over- or underuse (Birkmeyer et al. 1998). The ratio of the 
regional highest and lowest rate of THAs was 4.7-fold in the Medicare population in 
the USA (Birkmeyer 1998). THAs, coronary artery bypass grafting and transurethral 
prostatectomy were considered to have intermediate variation profiles, compared 
to the high variation profiles: of back surgery, lower extremity revascularization, 
and radical prostatectomy; and the low variation profiles of surgery for hip fracture 
and resection for colorectal cancer (Birkmeyer et al. 1998). In a previous study 
from Finland, the ratio of the regional highest and the lowest rate of THAs was 
threefold. The four procedures with the highest variability were lumbar disc and 
uterus operations, hemorrhoidectomy and THAs due to OA (Keskimäki et al 1994). 
In Denmark, the incidence ratio between counties with the highest and the lowest 
incidence rates of THA was only 1.4 (Pedersen et al. 2005). Dixon et al. (2006) 
reported that age- and sex-standardized incidence rates of THA varied by 25-30 
per cent in England in 2000. 
Several reports have dealt with explaining the variables related to the regional 
variation of THA (Keller et al. 1990, Peterson et al. 1992, Baron et al. 1996, Keskimäki 
et al. 1996, Wright et al. 1999, Söderman et al. 2000, Hawker et al. 2002, Hudak et 
al. 2002, Mahomed et al. 2003, Skinner et al. 2003, Milner et al. 2004, Pedersen 
et al. 2005, Dixon et al. 2006). Keller et al. (1990) suggested that the variation in 
the incidences of major orthopaedic procedures may be explained by differences 
in the number of orthopaedic surgeons among the regions. In a study carried out 
by Peterson et al. (1992), however, the THA rates among Medicare beneficiaries in 
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the USA were not associated with the orthopaedic surgeon density per se, although 
they were inversely proportional to the numbers of the Medicare population per 
square mile. Pedersen et al. (2005) reported no association between population 
density and the numbers of orthopaedic surgeons with the incidence variation in 
Denmark. In a study by Dixon et al. (2006), population size did not correlate with 
regional variation in England either.
The proportion of patients with primary OA of total number of the patients who 
received THA did not associate with the variation of the incidence rate in a study 
of Pedersen et al. (2005).
The incidence rates of THAs have been found to be low in several large cities 
including: London (Dixon et al. 2006), Copenhagen (Pedersen et al. 2005), 
Stockholm, Gothenburg and Malmö (Söderman et al. 2000). In a study emanating 
from England, people in rural areas were at least as likely to be managed for OA of 
the hip by their GPs and hospital consultants as their counterparts in urban areas 
(Milner et al. 2004).
In the study by Dixon et al. (2006), the numbers of limiting long-term illnesses 
and standardized mortality rates in a region offering THAs were not associated 
with the incidence rate of THAs per se. However, substantial variation in the 
incidence rates of THA against socio-economic status was found in England, with 
the most deprived fifth of the population experiencing significantly lower rates of 
surgery than those belonging to higher socio-economic groups (Dixon et al. 2004). 
Milner et al. (2004) reported that people in England who were socio-economically 
deprived were about twice as likely to be in need of THA, than those who were 
more prosperous but were less likely to receive those particular services. In a study 
based on data obtained from the Finnish Hospital Discharge Register for the 1987-
1988 period, the THA rates due to OA favoured the better-off. It was concluded, 
that although the Finnish health care system operates universal coverage without 
formal barriers to equal access, systematic socioeconomic inequity in the use of 
individual surgical treatments prevail (Keskimäki et al. 1996). In a more recent study 
by Dixon et al. (2006), social class and unemployment rates were not correlated 
with age-standardized operation rates in England. Pedersen et al. (2005) found no 
association between age- and sex-adjusted regional incidence rates of THA with 
hospital costs, or with GDP per capita in Denmark.
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6.5 the effect of hospitAl volume on performAnce of 
thA
6.5.1 the length of stAy And costs
The length of post-operative stay after THR varies. Although too early a discharge 
after THR has been cautioned against (Parvizi et al. 2007b), some THRs have even 
been performed as day-case surgery (Berger et al. 2004). However, reducing the 
length of stay lowers the cost of care per patient and allows for an increase in bed 
occupancy (Williams et al. 2005). Doro et al. (2006) studied 275,813 primary THAs 
from the Nationwide Inpatient Sample database including data of both Medicare 
and non-Medicare patients. Hospitals were divided into quartiles to differentiate 
low- and high-volume centres. The average length of stay for THA admissions was 
6.84 days for low volume hospitals, and decreased in each quartile to 5.78 days for 
the highest volume hospital quartile. Mitsuyasu et al. (2006) studied 1561 THA or 
total knee arthroplasty patients from 2001 to 2003 in 10 Japanese national hospitals 
and nine private hospitals. Participating hospitals were divided into either a high or a 
low volume group. These authors found that the mean length of stay was significantly 
shorter for the high volume group than for the low volume group. Further, total 
hospital charges were lower for the high volume group than for the low volume 
group. Kreder et al. (1997) stated that the duration of hospitalization was inversely 
related to surgeon volume and positively associated with hospital volume. Hospital 
charges were inversely related to hospital volume, even after adjusting for patient-
related factors and also other factors including: the duration of hospitalization, 
the year of the operation, and the destination after discharge. Martineau et al. 
(2005) analysed direct costs of 940 primary THAs of three Canadian hospitals. 
Mean in-hospital costs for patients having THAs in a high volume institution (≥300 
THAs/year) compared with two low-volume Canadian institutions (<300 THAs/
year) were: 3023 US dollars +/- 93 US dollars versus 4952 US dollars +/- 91 US 
dollars, respectively. It was stated, that as THAs continue to be scrutinized for cost 
containment, having the procedure carried out in a high volume centre seems to 
be an effective method of controlling costs.
Short length of stay (LOS) did not associate with low hospital volume in any of 
the studies found and reviewed. According to existing known litterature, elective 
THAs should be performed at high volume centres to reduce LOS and costs.
6.5.2 unscheduled re-Admissions 
Unscheduled re-admission rate is a national key performance indicator used by 
the UK Department oh Health (Adeyemo and Radley 2007). A 28-day emergency 
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re-admission rate has been used as a clinical indicator to compare surgical and 
orthopaedic performance between trusts in England and also in Scotland (Courtney 
et al. 2003). In a study conducted by Cullen et al. (2006), 8.5 per cent of patients 
were re-admitted within 28 days of discharge after THR. The main reasons of 
re-admission were thrombo-embolic complications, dislocations and wound 
complications. Reducing the LOS lowered the cost of care per patient and allowed 
for increased bed occupancy rates, but the effect on emergency readmission rates 
was equivocal (Williams et al. 2005). The odds ratio of emergency readmission 
for primary hip replacement was 0.54 when LOS was four to seven days and 0.55 
when it was eight to 14 days, whereas an odds ratio 1.0 was obtained, when the 
LOS was four days or less (Williams et al. 2005). Factors associated with increased 
odds of readmission were: being male, increasing socioeconomic deprivation and 
high numbers of co-morbidity conditions (Williams et al. 2005).
6.5.3. mortAlity
Katz et al. (2001) studied 58,521 primary THAs performed on patients covered by 
Medicare in the USA for the 1995-1996 period. Patients treated with primary THA 
in hospitals in which more than 100 procedures were performed per year had a 
lower risk of death than those treated in hospitals in which 10 or fewer procedures 
were performed per year (OR 0.58). Kreder et al. (1997) evaluated the hospital 
discharge register for Washington State for the 1988-1991 period. These authors 
determined the occurrence of death within three months and one year for 8,774 
THAs.  Patients of the lowest-volume surgeon group had three times the risk of 
dying within three months after elective THA than those in the highest-volume 
surgeon group. Moreover, patients who had been operated on in the highest-volume 
hospitals had significantly higher survival within one year after THA than those 
patients operated on in lower-volume hospitals. In a study based on Medicare data 
for the 1993-1994 period, Taylor et al. (1997) studied in-house and 30-day mortality 
against hospital volume.  Low-volume hospitals (fewer than 25 THAs annually) 
had a nearly four times greater in-house mortality and three times greater 30-
day mortality rate compared with high-volume hospitals in which more than 199 
procedures were done per year. Lavernia and Guzman (1995) published a report 
based on the Florida hospital discharge database. A total of 19,925 primary elective 
hip and knee arthroplasties were included. Surgeons with a low volume of THAs 
were associated with a higher mortality rate than high volume surgeons. Doro et 
al. (2006) studied 275,813 primary THAs from the Nationwide Inpatient Sample 
database including data of both Medicare and non-Medicare patients. Hospitals 
were divided into quartiles to differentiate low- and high-volume centres. Mortality 
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increased with decreasing hospital case volume, and the lowest volume hospitals 
had an adjusted odds ratio of 1.9. 
Low mortality did not associate with low hospital volume in any of the studies 
found and reviewed. According to the existing known literature, elective THAs 
should be performed at high volume centres in order to reduce mortality.  
6.5.4 dislocAtions
Dislocation rates during the first year after THR has been reported to range from less 
than one per cent to 3.9 per cent (Phillips et al. 2003, Khatod et al. 2006, Meek et al. 
2006). In a study by von Knoch et al. (2002), the incidence of dislocation increased 
with time, being 1.8 per cent at one year, seven per cent at five years and after that 
it increased to one per cent every subsequent five-year period. Several factors are 
constantly reported to be statistically associated with THR dislocation rates, these 
are: surgical diagnosis, femoral head size, patient age and gender, American Society 
of Anesthesiologists (ASA) score, cognitive dysfunction, surgical approach, surgeon 
volume and hospital volume (Meek et al. 2006).
In a study carried out by Solomon et al. (2002), 69 per cent fewer dislocations 
and infections occurred in hospitals in which more than 100 THRs were performed 
annually, compared with those hospitals in which fewer than 25 THRs were 
performed annually. Surgeon volume was the strongest predictor of adverse events. 
Katz et al. (2001) stated that patients treated with THR at hospitals and by surgeons 
with higher annual caseloads had lower rates of dislocation. In two systematic 
reviews of the literature by Battaglia et al. (2006) and Shervin et al. (2007), a 
positive association between higher hospital and surgeon volumes and lower rates 
of hip dislocation was found. 
6.5.5 infections
In recent studies, the rate of deep prosthetic infections was found to vary between 
0.6 per cent and 0.9 per cent after THR (Gastmeier et al. 2005, Muilwijk et al. 
2006, Phillips et al. 2006). Independent risk factors for surgical site infections after 
THR are: patient’s age, surgical diagnosis, ASA score and duration of operation 
(Ridgeway et al. 2005). In a systematic literature review, no association between 
hospital volume and infection rate was found (Shervin et al. 2007). 
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6.5.6 re-operAtions
In a study made by Dobzyniak et al. (2006), 39 per cent of all THR revisions 
were performed within five years after the index THR. Of these, 33 per cent were 
performed because of instability, 30 per cent for aseptic loosening and 14 per cent for 
infection. Clohisy et al. (2004) reported that instability was the commonest reason 
for early revision whereas osteolysis was the commonest reason for late revision. 
In a report based on data obtained from the Norwegian Arthroplasty Register, a 
high annual number of cemented THRs per hospital was not associated with lower 
revision rates, whereas the revision rate decreased with an increasing number of 
uncemented THRs (Espehaug et al. 1999). In a study by Manley et al. (2008), 
patients operated on by low-volume surgeons had a greater risk of arthroplasty 
revision at six months but no greater risk of revision at the time of longer-term follow-
up. No significant association between hospital volume and the rate of revisions 
of THA was found by Kreder et al. (1997), Judge et al. (2006) and Manley et al. 
(2008). However, Kreder et al. (1997) found an association between high surgeon 
volume and low rate of revisions within three months and within one year. 
study 1 study 2 study 3 study 4 study 5
study design Prospective, observational
Prospective, 
observational
Prospective, 
observational
Prospective, 
observational
Prospective, 
observational
types of data register-based register-based register-based register-based register-based
number of hips 50,968 34,549 19,859 34,642 28,218
females (%) 61 65 59 57 57
mean age (years) 70 72 68 68 68
mean follow up (years) 6.9 7.3 7.6 - 4.7
time period 1980-2004 1980-2005 1980-2005 1998-2005 1998-2005
number of hospitals 84 82 77 73 81
table 3. summary of study design, type of data, patients and follow-up time.
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7. aims of the Present stUdy
The main purpose of this study was to evaluate the survival of THA in patients 
aged 55 years and older at the time of primary THA on a nation-wide level and in 
addition to consider regional variation in incidence of THA and also the effects of 
hospital volume on the performance of THA. 
The specific aims of the studies were to assess:
1. The population-based survival of different THR concepts of primary total hip 
replacement for primary osteoarthritis for patients aged 55 years and older.
2. The population-based survival of primary cemented total hip replacements for 
primary osteoarthritis for patients aged 55 years and older.
3. The population-based survival of primary cementless total hip replacements 
for primary osteoarthritis for patients aged 55 years and older.
4. Regional variation in the incidence of primary THA due to primary OA and the 
factors associated with it.
5. The effects of hospital volume on the length of post-operative stay, unscheduled 
re-admissions, costs and complication rates related to THA on a population 
level.
36
Primary total hip arthroplasty for primary osteoarthritis in Finland
8. Patients and methods
8.1 pAtients
8.1.1 finnish ArthroplAsty register-bAsed studies (i, ii And iii)
In studies I, II and III, only patients aged 55 years and older at the time of the 
primary operation were included. In order to eliminate the effect of diagnosis as a 
confounding factor, only those patients with primary osteoarthritis as a recorded 
indication for operation were included.
During the study period covered in study I (from 1980 to 2004), 90,954 
primary total hip replacements were performed in Finland. Of these operations, 
80,805 (89%) were performed on patients aged 55 years and older. Primary OA 
was an indication in 81 per cent (n=65,673) of these operations. After excluding 
implants according to our study exclusion criteria (see Methods), 50,968 total hip 
replacements were included in the final analysis in study I. The mean age and 
gender distribution of the patients were recorded (Table 4). 
During the study period of study I, 135 different stem designs were used in 
Finland, of which 84 (62%) were used in fewer than 50 operations. Cementless stems 
were used in 29 per cent of the primary operations. During the same study period, 
132 different cup designs were used, of which 73 (55%) were used in fewer than 50 
operations. Cementless cups were used in 39 per cent of the primary operations 
during the study period. During the study period in study I, 4273 revision operations 
were performed on patients of the study group (Table 5). 
During the study period covered in study II (from 1980 to 2005), 101,720 primary 
total hip replacements were performed in Finland. Of these operations, 87,578 (86%) 
were performed on patients aged 55 years and over, and primary osteoarthritis was 
the indication in 81 per cent (n=71,146) of these operations. Of these 71,146 THRs, 
41,034 (58%) were cemented. The 12 most commonly used cemented replacements, 
i.e. cup + stem combinations, were identified and included in the final analyses 
in study II (Table 6, Table 7). These 12 replacements had been used in 34,549 
operations (84% of all cemented replacements). During the study period of study II, 
2,809 revision operations were performed on patients of the study group (Table 8).
During the study period of study III (1980-2005), 101,720 primary THRs 
were performed in Finland. Of these, 87,578 (86%) were performed on patients 
aged 55 years or older. Primary OA was the indication in 71,146 (81%) of these 
operations, and cementless total hip implants were implanted in 30,112 (42%). 
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Those designs used in more than 500 operations and also designs with more than 
20 hips at risk at five years were included in study III. These criteria permitted the 
inclusion of eight designs (10,310 replacements). All other designs were excluded. 
The risk of revision for each design was compared with that of 9,549 cemented 
reference implants (Tables 9 and 10). A 10-year survival rate exceeding 90 per 
cent is commonly regarded as a good long-term outcome (National Institute for 
Clinical Excellence, NICE). The three best performing cemented designs in Finland 
(study II) fulfilled this criterion and where chosen as the reference implants. These 
three cemented reference designs were the Exeter Universal stem combined with 
the All-poly cup (Stryker, Mahwah, NJ), the Müller Straight stem combined with 
the Müller Standard cup (Zimmer, Warsaw, Ind.) and the Lubinus SP II stem 
combined with the Lubinus IP cup (Waldemer Link, Hamburg, Germany). Revisions 
were linked to the primary operation by using the patient’s personal identification 
number, which is assigned to every resident in Finland. Numbers and indications 
for revisions were recorded (Table 11).
total  
hip replacement*
no. of hips duration of  
follow-up  (yr)
Age  (yr) women 
(%)
no. of  
hospitals
time period
Cementless group 1 7145 5.7 (0-18) 64 (55-87) 49 69 1986-2004
Cementless group 2 5743 6.3 (0-19) 65 (55-90) 53 65 1985-2004
Hybrid group 3784 4.9 (0-16) 70 (55-95) 59 55 1988-2004
Cemented group 34,296 7.1 (0-25) 72 (55-96) 65 81 1980-2004
total 50,968 6.9 (0-25) 70 (55-96) 61 84 1980-2004
Table 4. Demographic data on the patients with a total hip replacement analyzed in study I. * Cementless 
group 1 consisted of implants with a cementless, straight, proximally porous-coated stem and a modular, 
cementless, press-fit porous-coated cup, and cementless group 2 consisted of implants with a cementless, 
anatomic, proximally porous-coated and/or hydroxyapatite-coated stem with a modular, press-fit and/
or hydroxyapatite-coated cup. The values are given as the mean, with the range in parentheses. 
38
Primary total hip arthroplasty for primary osteoarthritis in Finland
TH
r
n
o.
A
se
pt
ic
 
lo
os
en
in
g 
(b
ot
h)
*
A
se
pt
ic
 
lo
os
en
in
g 
(c
up
)
A
se
pt
ic
 
lo
os
en
in
g 
(s
te
m
)
in
fe
ct
io
n
D
is
lo
ca
tio
n
m
al
po
si
tio
n
Fr
ac
tu
re
 
of
 t
he
 
pr
os
th
es
is
Pe
rip
ro
th
et
ic
 
fr
ac
tu
re
O
th
er
 
re
as
on
 £
To
ta
l
C
em
en
tle
ss
 G
ro
up
 #
1
71
45
54
 (
9.
5%
)
96
 (
16
.9
%
)
32
 (
5.
6%
)
19
 (
3.
3%
)
12
6 
(2
2.
2%
)
26
 (
4.
6%
)
21
 (
3.
7%
)
35
 (
6.
2%
)
15
9 
(2
8.
0
%
)
56
8 
(1
0
0
%
)
C
em
en
tle
ss
 G
ro
up
 #
2
57
43
50
 (
9.
8%
)
14
4 
(2
8.
2%
)
64
 (
12
.5
%
)
14
 (
2.
7%
)
39
 (
7.
6%
)
30
 (
5.
9%
)
15
 (
2.
9%
)
36
 (
7.
1%
)
11
8 
(2
3.
1%
)
51
0
 (
10
0
%
)
H
yb
rid
 T
H
r
37
84
17
 (
8.
0
%
)
16
 (
7.
5%
)
62
 (
29
.2
%
)
25
 (
11
.8
%
)
44
 (
20
.8
%
)
18
 (
8.
5%
)
4 
(1
.9
%
)
18
 (
8.
5%
)
8 
(3
.8
%
)
21
2 
(1
0
0
%
)
C
em
en
te
d 
TH
r
34
,2
96
10
36
 (
34
.7
%
)
47
6 
(1
6.
0
%
)
83
7 
(2
8.
1%
)
15
5 
(5
.2
%
)
23
3 
(7
.8
%
)
59
 (
2.
0
%
)
23
 (
0.
8%
)
10
5 
(3
.5
%
)
59
 (
2.
0
%
)
29
83
 (
10
0
%
)
to
ta
l
50
,9
68
11
57
73
2
99
5
21
3
44
2
13
3
63
19
4
34
4
42
73
ta
bl
e 
5.
 r
ea
so
ns
 f
or
 r
ev
is
io
ns
 in
 s
tu
dy
 i.
 n
o.
 =
 n
um
be
r 
of
 p
rim
ar
y 
op
er
at
io
ns
. *
n
um
be
r 
of
 r
ev
is
io
n 
op
er
at
io
ns
, p
er
ce
nt
ag
e 
of
 a
ll 
re
vi
si
on
s 
in
 p
ar
en
th
es
is
. £
O
th
er
 r
ea
so
n 
in
cl
ud
es
, f
or
 e
xa
m
pl
e,
 li
ne
r r
ev
is
io
ns
 d
ue
 to
 e
xc
es
si
ve
 w
ea
r. 
TH
r 
= 
to
ta
l h
ip
 re
pl
ac
em
en
t. 
Ce
m
en
tle
ss
 g
ro
up
 #
1 =
 a
 c
em
en
tle
ss
, s
tr
ai
gh
t, 
pr
ox
im
al
ly
 p
or
ou
s-
co
at
ed
 s
te
m
 w
ith
 
a 
m
od
ul
ar
, c
em
en
tle
ss
, p
re
ss
-fi
t p
or
ou
s-
co
at
ed
 c
up
. C
em
en
tle
ss
 g
ro
up
 #
2 
= 
a 
ce
m
en
tle
ss
, a
na
to
m
ic
, p
ro
xi
m
al
ly
 p
or
ou
s-
 a
nd
/o
r h
yd
ro
xy
ap
at
ite
-c
oa
te
d 
st
em
 w
ith
 a
 m
od
ul
ar
, 
pr
es
s-
fit
 a
nd
/o
r 
hy
dr
ox
ya
pa
tit
e-
co
at
ed
 c
up
.
39
thr brands number mean  follow-up mean age
women 
(%)
number of 
hospitals years of implantation
elite Plus/ 
elite Plus 885 6.3 72.2 66.3 14 1993-2004
Lubinus iP/ 
Lubinus iP 5790 12.0 69.4 65.4 36 1980-1995
Lubinus sP ii/ 
Lubinus iP 7240 8.1 72.3 66.7 48 1986-2005
Lubinus sP ii/ 
Lubinus FC 701 2.6 73.3 61.1 12 2000-2005
Lubinus sP ii/ 
Lubinus eccentric 2693 5.9 73.4 66.3 33 1988-2005
exeter/ 
exeter metal-backed 876 11.6 69.0 59.6 21 1981-1991
exeter Universal/ 
exeter All-poly 5048 5.9 73.1 64.9 42 1989-2005
exeter Universal/ 
exeter Contemporary 5572 2.9 72.9 61.5 51 1996-2005
müller straight/ 
müller std 2309 10.7 70.9 64.1 30 1980-1998
spectron eF/  
reflection all-poly 1929 1.8 73.6 65.7 29 1999-2005
Biomet interlok/ 
Biomet müller 581 7.5 73.3 71.1 15 1990-2004
Charnley/ 
Charnley LPW 925 11.0 68.8 63.0 17 1980-2003
together 34549 7.3 71.9 64.8 82
table 6. Demographic data in study ii.
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thr brands material surface special design features recent manufacturer
stems
elite Plus stainless steel matt  (Vaquasheen)
straight, small collar,  
proximal flange
Johnson & Johnson
Lubinus iP CoCr alloy matt straight, collar, monoblock,   iP=interplanta
 Link
Lubinus sP ii CoCr alloy matt anatomic, collar, modular,  sP=status Physiologus
Link
exeter stainless steel matt straight, collarless stryker Howmedica
exeter Universal stainless steel polished straight, collarless stryker Howmwdica
müller straight CoCr alloy matt straight, small collar,  fluted macrostructure
Zimmer
spectron eF CoCr alloy proximally  roughened straight, collar 
smith & nephew
Biomet interlok CoCr alloy matt straight, collar/collarless Biomet
Charnley flat-back stainless steel polished straight, collarless,  flat-backed 
Johnson & Johnson
cups
elite Plus UHmW poly - - Johnson & Johnson
Lubinus iP UHmW poly - iP=interplanta,  groove design
Link
Lubinus FC UHmW poly - flanged Link
Lubinus eccentric UHmW poly - deep design, snap fit Link
exeter metal-backed UHmW poly - metal backing stryker Howmedica
exeter All-poly UHmW poly - low/high version stryker Howmedica
exeter Contemporary UHmW poly - - stryker Howmedica
müller std UHmW poly - - stryker Howmedica
reflection UHmW poly/ 
XLPe poly - flanged, ridges/grooves 
smith & nephew
Biomet müller UHmW poly - - Biomet
Charnley LPW UHmW poly - LPW=long posterior wall Johnson & Johnson
table 7. material, surface and design of the femoral and acetabular components in study ii.
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thr brands number mean  follow-up mean age
women 
(%)
number of 
hospitals
years of 
implantation
Anatomic mesh/HG-ii 604 11.1 63 56 24 1989-1997
PCA std/PCA Pegged 508 11.6 63 55 23 1985-1995
Bi-metric/PFU 2,687 8.8 63 49 53 1986-2001
Bi-metric/mallory 637 8.7 67 60 11 1989-2000
Bi-metric/Vision 2,055 3.4 65 48 47 1998-2005
ABG i/ABG i 565 9.1 65 55 25 1992-1997
ABG i/ABG ii 1,765 5.9 66 51 36 1996-2003
ABG ii/ABG ii 1,489 2.5 67 55 31 2000-2005
Cemented reference 9,549 8.8 72 66 62 1980-2005
together 19,859 7.6 68 59 77 1980-2005
table 9. Demographic data of the implants analyzed in study iii. Abbreviations: HG-ii = Harris-Galante ii, PCA 
std = Porous Coated Anatomic standard, PFU = Press-Fit Universal and ABG = Anatomique Benoist Girard.
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thr brands material surface special design features manufacturer
stems
Bi-metric titanium alloy proximally porous coated straight, collarless Biomet
Anatomic mesh titanium alloy proximally porous coated anatomic Zimmer
ABG i titanium alloy proximally grit-blasted and  HA-coated anatomic
stryker Howmedica
ABG ii titanium alloy proximally grit-blasted and  HA-coated anatomic 
stryker Howmedica
PCA standard CoCr alloy proximally porous coated anatomic stryker Howmedica
exeter Universal stainless steel polished straight, collarless,  cemented 
stryker Howmedica
müller straight CoCr alloy matt straight, small collar,  fluted macrostructure
Zimmer
Lubinus sP ii CoCr alloy matt anatomic, collar,  modular 
Link
cups
ABG i titanium alloy grit-blasted and HA-coated hemispherical,  open screw-holes
stryker Howmedica
ABG ii titanium alloy grit-blasted and HA-coated hemispherical,  screw-holes plugged 
stryker Howmedica
Biomet mallory titanium alloy porous coated hemispherical,  open screw-holes, fins 
Biomet
Biomet Universal titanium alloy porous coated hemispherical,  open screw-holes
Biomet
Biomet Vision titanium alloy porous coated hemispherical,  screw-holes plugged
Biomet
Harris-Galante ii titanium alloy porous coated hemispherical,  open screw-holes
Zimmer
PCA Pegged cobalt-chromium porous coated hemispherical,  open screw-holes
stryker Howmedica
exeter All-poly polyeyhylene - cemented stryker Howmedica
müller std polyeyhylene - cemented Zimmer
Lubinus iP polyeyhylene -  groove design Link
table 10. material, surface, design features and manufacturer of the implants in study iii. Abbreviations: 
THr = total hip replacement, HG-ii = Harris-Galante ii, PCA = Porous Coated Anatomic, PFU = Press-Fit 
Universal and ABG = Anatomique Benoist Girard.
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8.1.2 hospitAl dischArge register-bAsed studies (iv And v)
The study population used in both studies IV and V was formed by selecting patients 
fulfilling the following criteria from the Hospital Discharge Register: International 
Classification of Diseases code (ICD-10, WHO) for primary OA or secondary OA for 
developmental dysplasia of the hip (M16.0, M16.1, M16.2 and M16.3) and operation 
codes defined by the Nordic Centre for Classifications in Health Care (NFB30 for 
cementless THA, NFB40 for hybrid THA, NFB50 for cemented THA, NFB60 for 
demanding THA and NFB99 for other THA procedures such as hip resurfacing) 
performed between years 1998-2005. Patients with a diagnosis of secondary OA for 
developmental dysplasia of the hip (M16.2 and M16.3) were included because there 
is variation in the use of codes for primary OA and for secondary OA due to the 
occurrence of developmental dysplasia. Patients who had congenital hip dislocation 
are allocated a different diagnosis code (Q65.0-Q65.9) to those of secondary OA 
for developmental dysplasia of the hip and were thus excluded from this study. 
Patients living in the autonomous province of Ahvenanmaa throughout the time 
of study period were excluded from the study, because an unknown number of 
those patients were operated on in Sweden. Only 0.5 per cent of Finnish citizens 
live in the province of Ahvenanmaa (Statistics Finland). In total 50 patients were 
excluded because they were living abroad.
In study IV, the numbers and incidences of THA for OA were reported separately 
for each hospital region. The municipality of residence of each patient determined the 
hospital region to which he or she belonged. According to Finnish law all inhabitants 
of Finland must belong to one of the hospital regions. The data from the largest 
hospital region of Helsinki and Uusimaa (HUHD) was divided into two districts as 
the HUHD population accounts for 30 per cent of the inhabitants in Finland. The 
subgroups were Helsinki for Helsinki city and Uusimaa for the rest of the Helsinki 
metropolitan area, which are comparable in size. The hospital region data were then 
calculated on a yearly basis for the years 1998 to 2005 inclusive. These data also 
include THAs performed in private hospitals region by region. Over the 1998 to 
2005 period, 44,093 primary THAs were performed in Finland. Of these, 34,642 
were included in study IV.
In study V, the diagnosis of secondary hip OA other than that for secondary OA 
due to DDH was noted retrospectively from the beginning of 1988. A patient was 
excluded, when there was a diagnosis of secondary hip OA in the Hospital Discharge 
Register between the beginning of 1988 and the day of operation (Table 12). Patients 
who had an entitlement to reimbursement from the Social Insurance Institution 
database for the following conditions were excluded: sequelae of transplantation, 
uraemia requiring dialysis, rheumatoid arthritis or connective tissue disease. Total 
hip replacements per se were evaluated according to the following: the length of 
stay, the length of uninterrupted institutional care and unscheduled re-admissions. 
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Thus, it was possible, that two THRs in the same patient could be evaluated. The 
total number of these THRs was 28,218. However, when considering re-operations, 
dislocations and infections, only cases for which the index THA was the only THA 
of the patient during years 1988-2006 were evaluated. The reason for this was 
that the side of the operation (left/right) was not reliably coded in the Hospital 
Discharge Register. If the data of the side of the operation is missing, then it would 
not be possible to identify the hip in question with certainty from the register data 
in order to evaluate the outcomes. Thus the total number of patients and hips in 
the analyses of re-operations, dislocations and infections was 22,084 (Table 13). 
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s72.0 Fracture of neck of femur
s72.1 Pertrochanteric fracture of femur
s72.2 subtrochanteric fracture of femur
m91.1 Juvenile osteochondrosis of head of femur (Legg-Calvé-Perthes)
m93.0 slipped upper femoral epiphysis (nontraumatic)
s324 Fracture of acetabulum
m45.* Ankylosing spondylitis
Q65.* Luxatio coxae congenita
m16.4 Post-traumatic coxarthrosis, bilateral
m16.5 Other post-traumatic coxarthrosis
m16.6 Other secondary coxarthrosis, bilateral 
m16.7 Other secondary coxarthrosis 
m16.9 Coxarthrosis, unspecified 
m87.* Osteonecrosis 
m00.* Pyogenic arthritis 
m05.* seropositive rheumatoid arthritis 
m06.* Other rheumatoid arthritis 
m07.* Psoriatic and enteropathic arthropathies 
m08.* Juvenile arthritis 
d66. Hereditary factor Viii deficiency 
d67. Hereditary factor iX deficiency 
d68. Other coagulation defects 
m36.2 Haemophilic arthropathy 
Q77. Osteochondrodysplasia with defects of growth of tubular bones and spine 
Q78. Other osteochondrodysplasias 
Q79. Congenital malformations of the musculoskeletal system, not elsewhere classified
table 12. exclusion criteria (iCD-10 diagnosis) in study V.
cohort number a (per cent) of hips number b (per cent) of hips
1998 3077 (9.4) 2060 (7.8)
1999 3033 (9.2) 2149 (8.2)
2000 3184 (9.7) 2322 (8.8)
2001 3337 (10.2) 2542 (9.6)
2002 3590 (10.9) 2819 (10.7)
2003 3896 (11.9) 3209 (12.2)
2004 3673 (11.2) 3123 (11.8)
2005 4428 (13.5) 3860 (14.6)
total 28218 (100) 22084 (100)
table 13. number a refers to annual number of hips in study V. number b refers to evaluation of re-
operations, dislocations and infections, when patients with unilateral THr implants only were evaluated 
over the 1988-2005 period. 
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8.2 methods 
8.2.1 finnish arthroPlasty reGister-Based stUdies (i, ii and iii)
To understand further the effects of age, we decided to perform analyses separately 
for three different age groups: 55 to 64 years, 65 to 74 years, and 75 years or over 
(I, II and III). 
In study I, total hip replacements (cup and stem combinations) that had 
been used in more than 50 operations during the study period were included. 
Consequently, prosthetic components with well-documented poor results such as 
cementless, smooth threaded cups, and implants that did not fit in any of the groups 
of interest were excluded.
In study II, only cemented designs used in more than 500 operations during 
the study period were included. These criteria permitted the inclusion of 12 THRs 
(cup + stem combinations).
The mean age of the patients and gender distribution were analysed (I, II and III). 
In study I, success rates of different implant groups were analysed. In total all 50,968 
THAs were classified in one of the four following THA groups: 1) a cementless, 
straight, proximally circumferentially porous-coated stem with a modular, porous-
coated press-fit cup (cementless group 1); 2) a cementless, anatomic, proximally 
circumferentially porous- and/or hydroxyapatite-coated stem, with a modular, 
porous- and/or hydroxyapatite-coated press-fit cup (cementless group 2); 3) a 
hybrid total hip replacement (a cemented stem combined with a modular, press-
fit cup); and 4) a cemented total hip replacement (a cemented loaded-taper or 
composite-beam stem combined with an all-polyethylene cup). 
In study I, a total of 50,968 femoral components were separately classified 
into four stem groups: 1) cementless, straight, proximally circumferentially 
porous-coated; 2) cementless, anatomic, proximally circumferentially porous- or 
hydroxyapatite-coated (fit and fill); 3) composite-beam cemented and 4) loaded-
taper cemented stems. 
In study I, a total of 50,968 acetabular components were also separately classified 
into three cup groups: 1) cementless, press-fit porous-coated; 2) cementless, press-
fit hydroxyapatite-coated and 3) cemented, all-polyethylene cups. 
In study II, the 12 most common cemented cup + stem combinations used during 
the study period were identified and included in the final analyses. 
In study III, the eight most common cementless cup + stem combinations used 
during the study period were determined and included in the final analysis. These 
eight cementless replacements were then compared with the three best performing 
cemented replacements in study II.
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8.2.2 hospitAl dischArge register-bAsed studies (iv And v)
In study IV, annual regional indices of the incidence of THA for primary OA were 
explained by the following independent variables: the region-specific ratio of primary 
THA for primary OA to that of primary THA for any reason, the need-adjusted 
expenses of specialized care (Hujanen et al. 2006), the proportion of patients aged 
from 18 to 64 years having permanent disability pension for orthopaedic disorders 
or connective tissue diseases, the morbidity-index, the average income in a region 
as estimated by state taxation, the relative number of orthopaedic surgeons and 
anesthesiologists, the population density and the average distance the inhabitants 
of a region had to travel to the nearest hospital performing THAs.
In study IV, the region-specific ratios of primary THA for primary OA (NFB30-
NFB99 for diagnosis codes M16.0, M16.1, M16.2, M16.3) to primary THA for any 
reason (NFB30-NFB99 for any reason) were calculated from the individuals’ data, 
which were obtained from the Hospital Discharge Registers. 
Need-adjusted expenses of specialized care were defined as net expenses of 
a municipality and of a region in relation to the need for those services by the 
population (Hujanen et al. 2006). The data of need-adjusted expenses of specialized 
care were gathered from the SOTKAnet Indicator Bank. The SOTKAnet Indicator 
Bank is an information service of the National Institute for Health and Welfare 
that provides key population welfare and health data from 1990 onwards for all 
Finnish municipalities. Thus SOTKAnet data are organized in terms of the current 
administrative division into municipalities. SOTKAnet is based on data gathered 
by the National Institute for Health and Welfare and also those data obtained from 
other agencies that gather welfare and health information. 
The morbidity index describes the health of the population of a specific 
municipality in relation to the average (set at a base index value of 100) for the 
country’s total population. The figure is calculated for each municipality in Finland, 
and is standardized for gender and age. The index is based on three register variables: 
mortality, the proportion of the working-aged population receiving disability pension 
for any reason, and also the proportion of the total population entitled to special 
refunds on medicines. Each variable is separately calculated in proportion to the 
average of the total population of the country with the value of 100 set as the index 
base. The final index value is given as the mean of the three sub-indices (The Sotka 
Indicator Bank). 
Data of the average incomes of a region as estimated by state taxation, data on 
population density and data on distances to the nearest hospital were obtained 
from Statistics Finland. Data of the number of orthopaedic surgeons and also the 
number of anesthesiologists were obtained from the Finnish Medical Association. 
Data on patients with disability pension due to orthopaedic disorders were obtained 
from SOTKA Indicator Bank.
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In study V, the effect of hospital volume on the length of surgical treatment 
period (later referred to as the length of stay and abbreviated to LOS), the length 
of uninterrupted institutional care (LUIC) the rate of unscheduled re-admissions, 
in addition to the numbers of re-operations, dislocations and infections were 
determined. The surgical treatment period was defined as the period when THR 
was performed in the hospital as recorded in the Hospital Discharge Register. A 
surgical treatment period ended either in discharge, in transmission to another 
facility or death of the patient. Uninterrupted institutional care was defined as the 
combination of the surgical treatment period and the period immediately following 
period of rehabilitation. Uninterrupted institutional care ended either with death 
of the patient or with discharge which included those patients transferred to 
another facility such as old people’s homes and institutions run by social welfare 
organisations. The maximum length of institutional care was limited to 60 days 
for calculation purposes. It was estimated with certainty that after 60 days patients 
stayed in institutional care for some other reason than the performed THR. There 
were only two patients during the whole study period who had received a period of 
uninterrupted institutional care lasting more than 60 days after THR. Re-operations, 
closed and open reductions of dislocated hip prostheses and infections of the THR 
were followed to the end of the year 2006.
In study V, hospitals were classified into four groups according to the number 
of THRs (NOMESCO-codes: NFB30-NFB99) performed annually during the study 
period: 1-50 (low volume hospitals, Group 1), 51-150 (average volume hospitals, 
Group 2), 151-300 (high volume hospitals, Group 3) and 301 or over (very high 
volume hospitals, Group 4) (Table 14). Low volume hospitals (Group 1) were used 
as a reference group. 
A reduction of a dislocated THR was defined in two different ways in the 
current study. First, a reduction of a dislocated THR was considered performed if 
there was a notification in the Hospital Discharge Register that either an open or 
closed reduction of a dislocated total hip prosthesis had been performed (NFH30 
or NFH32), associated with a diagnosis of an internal mechanical complication 
of endoprosthesis (ICD10: T84.0). However, closed reduction may also have 
been performed in the emergency room under light sedation anaesthesia. These 
patients are often discharged from the accidents and emergency units after closed 
reduction without an overnight stay in the hospital. According to regulations, it is 
mandatory to compile statistics on diagnosis codes in the accidents and emergency 
units but operational codes are not recorded routinely. Thus, a closed reduction of a 
dislocated THR was also considered to have been performed, when the patient had 
an unscheduled readmission with a diagnosis code of mechanical complication of the 
endoprosthesis (ICD: T84.0) but without admission as an inpatient. The hypothesis 
was that the majority of these cases are true dislocations, not periprosthetic 
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fractures or aseptic loosenings of the implant. We performed a pilot study where 
this hypothesis was confirmed. 
In study V, a diagnosis code for deep prosthetic infection (ICD-10: T84.5) was 
used in data search from the beginning of the surgical treatment period to the 
end of the follow-up. The data from the Finnish Arthroplasty Register was used to 
determine the numbers of re-operations performed due to deep prosthetic infections. 
Infected hips requiring a re-operation were included in the total number of deep 
prosthetic infections.
In study V, an unscheduled re-admission was recorded, when a patient was re-
admitted to hospital or had a contact with the out-patient department or accident 
and emergency unit of any hospital in Finland during the first 14 and 42 days 
following the end of the surgical treatment period. Unscheduled re-admissions due 
to dislocations were included in all unscheduled readmissions. 
In study V, the prices of a bed-day in hospital care and in primary health care 
were used in determining the amount of money saved when LOS diminishes. The 
price of a bed-day in hospitals performing THRs was on average 527 euros in 
Helsinki and Uusimaa district (HUS) during 2003-2005 (Peltola 2008). The price 
of a day of treatment in the whole country on average was not available. The price 
of a day of treatment in health care centres was 141 euros on average in Finland 
(Hujanen et al. 2008). 
8.2.3 stAtisticAl methods (i, ii, iii, iv, v)
In studies I, II and III, the end point for survival was defined as revision when 
either one component (including liner and femoral head) or the whole implant 
was removed or exchanged. Both revision for any reason and revision for aseptic 
loosening served separately as end points. Revisions were linked to the primary 
operation by using the unique personal identification number assigned to each 
resident of Finland. Kaplan-Meier survival calculations were used to predict survival 
of implants at 10, 15 and 20 years (study I), at five, 10, 15 and 20 years (study 
II) and at seven, 10 and 15 years (study III) follow-up. At each follow-up time 
point, survival rates were only analysed for implants with more than 20 patients 
at risk. Survival data obtained by Kaplan-Meier analysis were compared using the 
log-rank test. Patients who died or emigrated from Finland during the follow-up 
period were censored at that point. The Cox multiple regression model was used 
to study differences between implants (study II and III) and implant groups (study 
I) in order to adjust for potential confounding factors. The factors studied with the 
Cox model were implants (studies II and III), implant groups (study I), age and 
gender. When stem groups were analysed using the Cox model in study I, loaded-
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taper cemented stems with well documented good long-term results served as the 
reference group. Similarly, all-polyethylene, cemented cups served as the reference 
group for analysing the acetabular side, whereas the cemented total hip replacements 
were used as the reference group for analysing total hip replacements. The Charnley 
prosthesis was chosen as the reference design in study II, because it is considered 
to be the gold standard when analysing long term results of THA. In study III, the 
three best performing cemented designs in Finland as identified in study II were 
chosen as the reference implants. These three cemented designs were the Exeter 
Universal stem combined with the All-poly cup, the Müller Straight stem combined 
with the Müller Standard cup and the Lubinus SP II stem combined with the Lubinus 
IP cup (Waldemer Link, Hamburg, Germany). When the effects of age and sex on 
implant survival were analysed using the Cox model, adjustment was also made for 
the THR groups (study I). Cox regression analyses provided estimates of survival 
probabilities and adjusted risk ratios for revision. Estimates obtained by the Cox 
analyses were used to construct adjusted survival curves at mean values of the risk 
factors. The Wald test was used to calculate p-values for data obtained from the 
Cox multiple regression analysis. A difference between groups was considered to 
be statistically significant if the p-values were less than 0.05 in a two-tailed test 
(studies I, II and III).
Both Kaplan-Meier and Cox regression are methods based on assumptions of 
independent observations. However, bilateral observations cannot be regarded as 
independent (Robertsson and Ranstam 2003, Bryant et al. 2006). Violation of 
this independence assumption may have an effect on the validity of the results. 
To avoid this violation, the data analysis could be performed by including only the 
correlated observations. This could be done by allowing only one prosthesis per 
patient or by including a shared frailty variable in the Cox regression. In studies 
I, II and III, bilateral observations were included in the analysed dataset. It has 
been found that the effect of neglecting bilateral prostheses is minute (Havelin et 
al. 1995, Robertsson and Ranstam 2003, Lie et al. 2004). 
In study III, the proportional hazards assumption of the Cox model (meaning 
that the relative difference between revision rates should be constant over the time 
elapsed since the primary operation) was not reached in some analyses performed. 
Therefore, adjusted risk ratios were also established within time intervals (0-7 years, 
>7 years after the primary operation).
In study IV, regional incidences were reported both as unadjusted and adjusted 
for age and gender to improve comparisons. Patients were divided into the following 
cohorts: those under 40 years, those from 40 to 85 years, and those over 85 years. 
The 40 to 85 year old cohort was further divided into nine sub-cohorts with each sub-
cohort comprising a five year increment sequentially up to 85 years. Adjustments 
were performed in relation to the average level of the year concerned (index 100). 
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We estimated the variation of regional rates by the method of extreme quotients 
(EQ = minimum/maximum) (Keskimäki et al. 1994). 
In study IV, a least squares with fixed effects panel model for the statistical 
modeling of our data set was used, in order to determine which variables were 
associated with the relative frequency i.e. the regional incidence of primary THA 
operations. In the panel model, the number of years investigated was eight, and the 
number of regions was 21 each year making 168 observations in total.
In study V, variables were adjusted for confounding factors to improve the 
comparability of the data. Adjustments were performed by modelling the effect 
of the confounding factors, first by using the logistic regression model (two-class 
variables) or by using the generalized linear model (gamma-distribution, log-link, 
continuous variables). Then the prediction produced by the model for every patient 
was used to count the anticipated events. In addition, 95 per cent confidence intervals 
(95% CI) were determined. Several different factors were used in the adjustments. 
The age of the patient (under 40 years, over 40 years divided into nine groups of 
five year increments up to 85 years, and older than 85 years), the patient’s sex, 
previous THA and co-morbidities (Table 15) were used in all adjustments. We 
also performed calculations using head size of the prosthesis in the adjustments 
to eliminate the effect of head size on the dislocation rates. Co-morbidities were 
determined using diagnoses of Hospital Discharge Register from the beginning of 
the year 1987 to the date of the operation, using the Social Insurance Institution 
database for entitlement to reimbursement and use and cost of drugs. The illnesses 
chosen were such that might have an effect on the performance of THR, on LOS 
or the rate of complications. The period elapsed between operation and follow-up 
time was used in adjusting the rate of complications.
8.2.4 ethicAl considerAtions
The National Agency for Medicines gave its permission to use data of the Finnish 
Arthroplasty Register. The National Institute of Health and Wellfare (THL) gave 
its permission to use data of the Hospital Discharge Register and other registers 
it held. Patients were not contacted personally and, therefore, permission of the 
ethical commitee was not needed for register-based studies.
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9. resUlts
The survival data of subgroups by age are not shown to make Tables easier to read.
9.1 the finnish ArthroplAsty register-bAsed studies (i, 
ii And iii)
9.1.1 femorAl components
9.1.1.1 Stem groups, survival rate for aseptic loosening
In study I, the 10- and 15-year survivorship of cementless stems for aseptic loosening 
for all patients studied was higher than that of cemented stems (Table 16). The 
Cox regression analyses revealed that cementless stem groups had a significantly 
lower risk of revision due to aseptic loosening than the cemented stem groups 
(Table 16, Figure 1). For the subgroups of patients aged 55 to 64 years and 65 to 74 
years, cementless stem groups had a significantly lower risk of revision for aseptic 
loosening than the cemented stem groups. For patients aged 75 years and older, 
the difference in risk of revision between cementless and cemented groups was not 
statistically significant.
9.1.1.2 Cemented stems, survival rate for aseptic loosening
At 15-years in study II, the overall survival rate of the Exeter Universal stem was 
96 per cent and that of the Charnley stem 79 per cent. The Cox regression analyses 
revealed that five stem designs had a significantly lower risk of revision when 
compared to the reference design, the Charnley stem (Table 17, Figure 2). 
For patients aged from 55 to 64 years in study II, the Exeter Universal stem 
had a 10-year survival rate exceeding 95 per cent, and a 15-year survival rate of 
more than 90 per cent. 
For patients aged from 65 to 74 years in study II, survival of the Exeter Universal 
and the Müller Straight stems exceeded 90 per cent at 15-years.
For patients aged 75 years and older, all femoral components excluding the 
Spectron showed survivorship of over 90 per cent at 10 years. 
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figure 1. Cox-adjusted survivorship curves of 50,968 stems in patients who were fifty-five years of age or 
older, stratified according to the stem groups. The end point was defined as revision of the stem because 
of aseptic loosening. Adjustment was made for age and sex. HA = hydroxyapatite.  
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figure 2. Cox-adjusted survival curves of 34,549 stems in patients aged 55 years or older in study ii, with 
stem brands as the strata factor. The end point was defined as stem revision due to aseptic loosening. 
Adjustment has been made for age and gender.
9.1.1.3 Cementless stems, survival rate for aseptic loosening
When all patients aged 55 years or more were analysed as a single group, the 
Bi-Metric stem had a higher survival rate at 15 years than that of the reference 
group. The Cox regression analyses revealed that all cementless stems studied had 
a statistically significantly reduced risk of revision during the first seven years after 
the primary operation when compared to the reference group (Table 18). Beyond 
seven years of follow-up, the Bi-Metric and the ABG I stems still had significantly 
lower revision risks than the cemented reference group (Table 18, Figure 3).
For age groups 55 to 64 years and 65 to 74 years, the Bi-Metric stem had a 
higher 15-year survival rate than the reference group [95% (CI 92-97) vs. 84% (CI 
80-87) and 98% (CI 97-99) vs. 90% (CI 89-91)], respectively.
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9.1.2 AcetAbulAr components
9.1.2.1 Cup groups, survival rate for aseptic loosening
In study I, the 10-year survivorship of cementless and cemented cups for aseptic 
loosening for all patients studied was nearly the same (Table 19). Cox regression 
analyses for all patients studied revealed that cementless cup groups had a significantly 
lower risk of revision for aseptic loosening than cemented all-polyethylene cups 
(Table 19, Figure 4). For the subgroups of patients aged 55 to 64 years and 65 to 
74 years, the cementless cup groups had a significantly lower risk of revision for 
aseptic loosening than the cemented all polyethylene cups. For the subgroup of 
patients aged 75 years and older, cementless, hydroxyapatite-coated press-fit cups 
had significantly reduced risk of revision than the cemented all-polyethylene cups.
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Figure 3. Cox-adjusted survival curves of 19,859 stems in patients aged 55 years or older with stem designs as the strata factors. The end 
point was defined as stem revision due to aseptic loosening. Adjustment was made for age and gender. Abbreviations; PCA = Porous Coated 
Anatomic and ABG = Anatomique Benoist Girard. 
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figure 3. Cox-adjusted survival curves of 19,859 stems in patients aged 55 years or older with stem designs 
as the strata factors. The end point was defined as stem revision due to aseptic loosening. Adjustment 
was made for age and gender. Abbreviations; PCA = Porous Coated Anatomic and ABG = Anatomique 
Benoist Girard.
62
Primary total hip arthroplasty for primary osteoarthritis in Finland
A
ge
 g
ro
up
cu
p 
gr
ou
p
n
*
m
f 
yr
A
r
  
10
 y
r
%
 1
0
-y
ea
r 
su
rv
iv
al
  
(9
5 
%
 c
i)
A
r
  
15
 y
r
%
 1
5-
ye
ar
 
su
rv
iv
al
  
(9
5 
%
 c
i)
A
r
  
20
 y
r
%
 2
0
-y
ea
r 
su
rv
iv
al
  
(9
5 
%
 c
i)
A
dj
us
te
d 
r
r
  
fo
r 
re
vi
si
on
  
(9
5 
%
 c
i)
p
A
ll 
 
(≥
 5
5 
ye
ar
s)
C
em
en
tle
ss
, m
od
ul
ar
,  
pr
es
s-
fit
 p
or
ou
s-
co
at
ed
 
10
,9
73
6.
4
2,
64
4
96
(9
5-
96
)
22
7
84
(8
1-
88
)
1
-
0.
54
(0
.4
7-
0.
62
)
<0
.0
0
1
C
em
en
tle
ss
, m
od
ul
ar
,  
pr
es
s-
fit
 H
A
-c
oa
te
d 
5,
69
9
4.
4
45
7
95
(9
4-
97
)
1
-
-
-
0.
42
(0
.3
2-
0.
54
)
<0
.0
0
1
C
em
en
te
d 
 
al
l-
po
ly
et
hy
le
ne
34
,2
96
7.
1
10
,3
0
9
95
(9
4-
95
)
3,
56
7
88
(8
7-
89
)
83
2
83
(8
1-
84
)
1.0
-
To
ta
l
50
,9
68
ta
bl
e 
19
. s
ur
vi
va
l o
f c
up
 g
ro
up
s 
in
 s
tu
dy
 i.
 T
he
 e
nd
 p
oi
nt
 w
as
 d
efi
ne
d 
as
 re
vi
si
on
 d
ue
 to
 a
se
pt
ic
 lo
os
en
in
g 
of
 t
he
 c
up
. 1
0-
, 1
5-
, a
nd
 2
0-
ye
ar
 
su
rv
iv
al
 ra
te
s 
ob
ta
in
ed
 fr
om
 t
he
 K
ap
la
n-
m
ei
er
 a
na
ly
si
s. 
n
 =
 n
um
be
r 
of
 p
rim
ar
y 
op
er
at
io
ns
. m
F 
= 
m
ea
n 
fo
llo
w
-u
p 
(y
ea
rs
). 
A
r 
= 
at
 r
is
k.
 r
r 
= 
ris
k 
ra
tio
 f
ro
m
 t
he
 C
ox
 r
eg
re
ss
io
n 
an
al
ys
is
 (
ot
he
r 
cu
p 
gr
ou
ps
 w
er
e 
co
m
pa
re
d 
w
ith
 t
he
 a
ll-
po
ly
et
hy
le
ne
, c
em
en
te
d 
cu
ps
; a
dj
us
tm
en
t 
m
ad
e 
fo
r 
ag
e 
an
d 
ge
nd
er
). 
H
A
 =
 h
yd
ro
xy
ap
at
ite
.
63
76
Figure 4. Cox-adjusted survival curves calculated for 50,968 cups with cup group as the strata factor in study I. The end point was defined as 
cup revision due to aseptic loosening. Adjustment was made for age and gender.
2520151050
Years postoperatively
1.0
0.9
0.8
0.7
0.6
C
um
ul
at
iv
e 
S
ur
vi
va
l
All-poly cemented
Press-fit HA-coated uncemented
Press-fit porous-coated uncemented
Cup concepts
Cup concepts - aseptic loosening
figure 4. Cox-adjusted survival curves calculated for 50,968 cups with cup group as the strata factor in 
study i. The end point was defined as cup revision due to aseptic loosening. Adjustment was made for 
age and gender.
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9.1.2.2 Cemented cups, survival rate for aseptic loosening
In study II, at 15 years, only the Exeter All-poly and the Müller Standard acetabular 
components exceeded survivorship of 90 per cent when all patients aged 55 years 
or older were analysed. Cox regression analysis showed that three acetabular 
components had a significantly reduced risk of revision when compared with the 
Charnley reference design (Table 20, Figure 5).
For the patients aged from 55 to 64 years of study II, the Exeter All-poly was 
the only cup with a significantly lower risk of revision than the Charnley LPW cup.
For the patients aged from 65 to 74 years of study II, the Exeter All-poly and the 
Müller Standard cups had a significantly lower risk of revision than the Charnley 
LPW cup.
For the patients older than 74 years of study II, all cup designs with available 
follow-up data, except the Exeter Metal-backed cup, had survival rates of 95 per 
cent or more. 
9.1.2.3 Cementless cups, survival rate for aseptic loosening
When all patients aged 55 years or more were analysed as a single group, the 
survival of the PCA Pegged cup at 15 years was lower than that of the reference 
group. Apart from this exception, there were no differences in survival rates between 
cementless cups and that of the reference group at 15-years. The Cox regression 
analyses revealed that the PCA Pegged cup had a significantly increased risk of 
revision both during the first seven years postoperatively and beyond seven years 
of follow-up. Furthermore, during the first seven years the Press-Fit Universal, 
the Mallory, the Vision and the ABG II cups had significantly decreased risks of 
revision compared to the reference group (Table 21). Beyond seven years of follow-
up, however, only the Press-Fit Universal cup still retained the lower revision risk 
(Table 21, Figure 6). The Vision and the ABG II cups were found to be scarce in 
the beyond the seven year analysis (Table 21).
For patients aged 55 to 64 years, the HG-II cup [87% (CI 82-91)] and the PFU 
cup [88% (CI 84-93)] had similar survival rates at 15 years as the reference cups 
[85% (CI 81-88)]. For patients aged 65 to 74 years, the PFU cup had a higher survival 
rate at 15 years than the reference group [96% (CI 94-98) vs. 92% (CI 91-93)].
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Figure 5. Cox-adjusted survival curves of 34 549 cups in patients aged 55 years or older, with cup 
brands as the strata factor in study II. The end point was defined as cup revision due to aseptic 
loosening.  Adjustment has been made for age and gender. 
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figure 5. Cox-adjusted survival curves of 34 549 cups in patients aged 55 years or older, with cup brands as 
the strata factor in study ii. The end point was defined as cup revision due to aseptic loosening.  Adjustment 
has been made for age and gender.
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Age group cup brand n* mf yr Ar  7 yr
% 7-year  
survival  
(95% ci)
Ar  
10 yr
% 10-year  
survival  
(95% ci)
Ar  
15 yr
% 15-year  
survival  
(95% ci)
Adjusted rr  
for revision  
(95% ci)
p-value
All (≥ 55 
years) HG-ii 604 11.1 531 99 (98-100) 445 97 (95-98) 92 88 (84-92) 0.75 (0.53-1.05)  0.09
FU ≤7 years 0.50 (0.24-1.03) 0.06
FU > 7 years 0.82 (0.56-1.22) 0.3
PCA Pegged 508 11.6 432 94 (92-96) 353 86 (83-89) 148 75 (70-80) 1.91 (1.49-2.44) <0.001
FU ≤7 years 2.21 (1.44-3.38) <0.001
FU > 7 years 1.70 (1.26-2.30) <0.001
PFU 2,687 8.8 2,035 98 (97-99) 1,192 97 (96-98) 145 91 (87-94) 0.54 (0.42-0.70) <0.001
FU ≤7 years 0.68 (0.47-0.99) 0.04
FU > 7 years 0.45 (0.32-0.64) <0.001
mallory 637 8.8 517 99 (98-100) 275 96 (94-98) 10 - 0.52 (0.31-0.86) 0.012
FU ≤7 years 0.35 (0.14-0.85) 0.02
FU > 7 years 0.68 (0.37-1.26) 0.2
Vision 2,055 3.4 152 99 (98-100) 0 - 0 - 0.49 (0.27-0.89) 0.019
FU ≤7 years 0.51 (0.27-0.97) 0.04
FU > 7 years 3.39 (0.47-24.75) 0.2
ABG i 565 9.1 454 98 (96-99) 330 93 (90-95) 0 - 1.17 (0.83-1.66)  0.4
FU ≤7 years 0.81 (0.43-1.52) 0.5
FU > 7 years 1.46 (0.96-2.24) 0.08
ABG ii 3,254 4.3 700 99 (99-100) 14 - 0 - 0.20 (0.11-0.38) <0.001
FU ≤7 years 0.22 (0.11-0.43) <0.001
FU > 7 years 0.19 (0.03-1.37) 0.1
Cemented 
reference 9,549 8.8 6,221 98 (98-98) 4,441 96 (96-97) 1,113 92 (91-93) 1.0 --
FU ≤7 years 1.0 -
FU > 7 years 1.0 -
Total 19,859
table 21. survival of cementless cups and the cemented reference group in study iii. end-point is defined as revision 
due to aseptic loosening of the cup. 7-, 10-, and 15-year survival rates were obtained from the Kaplan-meier analysis. 
Abbreviations: n* = number of operations, mF = mean follow-up (years), Ar = at risk, rr = risk ratio from the Cox 
regression analysis (other cup brands compared to the cemented reference cups; adjustment made for age and 
gender), HG-ii = Harris-Galante ii, PCA = Porous Coated Anatomic, PFU = Press-Fit Universal and ABG = Anatomique 
Benoist Girard.
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84
Figure 6. Cox-adjusted survival curves of 19,859 cups in patients aged 55 years or older with cup designs as the strata factors in study III. The 
end point was defined as cup revision due to aseptic loosening. Adjustment was made for age and gender. Abbreviations; PCA = Porous 
Coated Anatomic and ABG = Anatomique Benoist Girard.  
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fi re 6. Cox-adjusted urvival curves of 19,859 cups in patients aged 55 years or older with cup designs 
as the strata factors in study iii. The end point was defined as cup revision due to aseptic loosening. 
Adjustment was made for age and gender. Abbreviations; PCA = Porous Coated Anatomic and ABG = 
Anatomique Benoist Girard. 
9.1.3 totAl hip replAcements
9.1.3.1 Total hip replacement groups
9.1.3.1.1 Survival rate for aseptic loosening
In study I, the 10-year survivorship for all patients studied of cementless group 1 
was higher than that of the other groups (Table 22). Both cementless groups and 
also the hybrid group had significantly lower risks of revision than the group of 
cemented replacements as determined by Cox regression analysis (Table 22, Figure 
7). For the subgroups of patients aged 55 to 64 years and 65 to 74 years, cementless 
groups had a significantly lower risk of revision than the cemented group. For the 
subgroup of patients aged 75 years and older, the differences in risk of revision 
between groups were not statistically significant. 
69
9.1.3.1.2 Survival rate for any reason
The 10-year survivorship for any reason of the cemented group for all patients studied 
was slightly higher than that of the other groups (Table 23). The Cox regression 
analysis for all patients studied and for the subgroups of age found no statistically 
significant differences in risk of revision between the groups (Table 23, Figure 8).
9.1.3.2 Cemented total hip replacements 
9.1.3.2.1 Survival rate for aseptic loosening
At 15 years in study II, survival of only the Exeter Universal/Exeter All-poly exceeded 
90 per cent for aseptic loosening. The Cox regression analyses revealed that the Elite 
Plus prosthesis had a higher risk of revision than the Charnley prosthesis (Table 
24, Figure 9). For patients aged 55 to 64 years, the Exeter Universal/Exeter All-
poly had a 15-year survival of 84 per cent. The Charnley prosthesis had a 20-year 
survival of 55 per cent for this same group. For patients aged 65 to 74 years, the 
15-year survival of the Exeter Universal/Exeter All-poly and the Müller prosthesis 
for aseptic loosening exceeded 90 per cent. For patients aged 75 years or older, 
three designs had a substantially lower risk of revision than the Charnley prosthesis.
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Figure 7. Cox-adjusted survival curves calculated for 50,968 total hip replacements with implant 
group as the strata factor in study I. The end point was defined as revision of the stem and/or the 
cup due to aseptic loosening. Adjustment was made for age and gender.  
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figure 7. Cox-adjusted survival curves calculated for 50,968 total hip replacements with implant group 
as the strata factor in study i. The end point was defined as revision of the stem and/or the cup due to 
aseptic loosening. Adjustment was made for age and gende .
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Figure 8. Cox-adjusted survival curves calculated for 50,968 total hip replacements with 
implant groups as the strata factor in study I. The end point was defined as revision for any 
reason. Adjustment was made for age and gender.
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figure 8. Cox-adjusted survival curves calculated for 50,968 total hip replacements with implant groups 
as the strata factor in study i. The end point was defined as revision for any reason. Adjustment was made 
for age and gender. 
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Figure 9. Cox-adjusted survival curves of 34 549 total hip replacements in patients aged 55 years 
or older in study II, with THR brands as the strata factor. The end-point was defined as cup and/or 
stem revision due to aseptic loosening.  Adjustment has been made for age and gender. 
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figure 9. Cox-adjusted survival curves of 34 549 total hip replacements in patients aged 55 years or older 
in study ii, with THr brands as the strata factor. The end-point was defined as cup and/or stem revision 
due to aseptic loosening.  Adjustment has been made for age and gender.
9.1.3.2.2 Survival rate for any reason
At 15 years in study II, survival of the Exeter Universal/Exeter All-poly and the 
Müller prosthesis was 88 per cent (Table 25), when revision for any reason was 
considered as the end-point. The Cox model determined that five designs had a 
reduced risk of revision as compared to the Charnley prosthesis (Table 25). For 
patients aged 55 to 64 years, the Exeter Universal/Exeter All-poly had a 15-year 
survival rate for any reason of 80 per cent. For patients aged 65 to 74 years, the 
Exeter Universal/Exeter All-poly and the Müller prosthesis had 15-year survival 
rates exceeding 85 per cent. For patients aged 75 years or older, three designs had 
lower risks of revision than the Charnley prosthesis.
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9.1.3.3 Cementless total hip replacements 
9.1.3.3.1 Survival rate for aseptic loosening
When all patients aged 55 years or more were analysed as a single group, the 15-
year survival rate for aseptic loosening of the PCA Standard/PCA Pegged was lower 
than that of the reference group. Cox regression analysis revealed that the PCA 
Standard/PCA Pegged design had a significantly increased risk of revision beyond 
seven years of follow-up. In contrast, all other cementless cup designs had lower 
risks of revision than the cemented reference group during the first seven years. 
These lower risks of revision even continued for the Bi-Metric/Press-Fit Universal, 
the Bi-Metric/Mallory and the ABG I/ABGII beyond seven years (Table 26, Figure 
10). Beyond seven years, the number of the Bi-Metric/Vision THRs was scarce, 
however (Table 26).
For patients aged from 55 to 64 years, the 15-year survival rate of the Bi-Metric/
Press-Fit Universal design was higher than that of the reference group [88% (CI 
84-92) vs. 78% (CI 74-82)]. Moreover, for patients aged 65 to 74 years, the survival 
rate at 15 years for the Bi-Metric/Press-Fit Universal [95% (CI 93-98)] was higher 
than that of the reference group [87% (CI 86-89%)]. 
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Age group thr n* mf yr Ar  7 yr
% 7-year 
survival 
(95% ci)
Ar  
10 yr
% 10-year 
survival 
(95% ci)
Ar  
15 
yr
% 15-year 
survival 
(95% ci)
Adjusted rr  
for revision  
(95% ci)
p-value
All  
(≥ 55 years)
Anatomic mesh/
HG-ii 604 11.1 532 97 (96-98) 445 94 (92-96) 92 85 (80-89) 0.68 (0.51-0.90) 0.006
FU ≤7 years 0.52 (0.32-0.86) 0.01
FU > 7 years 0.75 (0.53-1.06) 0.11
PCA std/PCA 
Pegged 508 11.6 433 92 (90-95) 354 83 (80-87) 148 71 (66-76) 1.48 (1.19-1.83) <0.001
FU ≤7 years 1.37 (0.96-1.96) 0.09
FU > 7 years 1.46 (1.11-1.92) 0.006
Bi-metric/PFU 2,687 8.8 2,035 98 (97-98) 1,192 96 (96-97) 145 90 (87-93) 0.37 (0.29-0.46) <0.001
FU ≤7 years 0.39 (0.29-0.54) <0.001
FU > 7 years 0.34 (0.25-0.47) <0.001
Bi-metric/mallory 637 8.8 517 99 (98-100) 275 96 (94-98) 10 - 0.36 (0.23-0.58) <0.001
FU ≤7 years 0.27 (0.13-0.55) <0.001
FU > 7 years 0.48 (0.26-0.88) 0.02
Bi-metric/Vision 2,055 3.4 152 99 (98-99) 0 - 0 - 0.37 (0.23-0.60) <0.001
FU ≤7 years 0.37 (0.23-0.62) <0.001
FU > 7 years 2.53 (0.35-18.38) 0.4
ABG i/ABG i 565 9.1 455 97 (96-99) 330 92 (90-95) 0 - 0.75 (0.54-1.04) 0.09
FU ≤7 years 0.51 (0.29-0.87) 0.01
FU > 7 years 1.03 (0.68-1.55) 0.9
ABG i/ABG ii 1,765 5.9 700 99 (99-100) 14 - 0 - 0.12 (0.06-0.22) <0.001
FU ≤7 years 0.12 (0.06-0.24) <0.001
FU > 7 years 0.13 (0.02-0.93) 0.04
ABG ii/ABG ii 1,489 2.5 0 - 0 - 0 - 0.33 (0.15-0.74) 0.007
FU ≤7 years 0.34 (0.15-0.76) 0.009
FU > 7 years - -
Cemented 
reference 9,549 8.8 6,234 96 (96-96) 4,447 93 (93-94) 1,116 88 (87-89) 1.0 -
FU ≤7 years 1.0 -
FU > 7 years 1.0 -
Total 19,859
table 26. survival of cementless total hip replacements and the cemented reference group in study iii. end-point is defined 
as revision due to aseptic loosening of the cup and/or the stem. 7-, 10-, and 15-year survival rates were obtained from 
the Kaplan-meier analysis. Abbreviations: THr = total hip replacement, n* = number of operations, mF = mean follow-up 
(years), Ar = at risk, rr = risk ratio from the Cox regression analysis (other brands compared to the cemented reference 
designs; adjustment made for age and gender), HG-ii = Harris-Galante ii, PCA = Porous Coated Anatomic, PFU = Press-Fit 
Universal and ABG = Anatomique Benoist Girard.
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Figure 10. Cox-adjusted survival curves of 19,859 total hip replacements in patients aged 55 years or older with total hip replacement design as 
the strata factor in study III. The end point was defined as revision of the stem and/or the cup due to aseptic loosening. Adjustment was made 
for age and gender. Abbreviations; PCA = Porous Coated Anatomic, ABG = Anatomique Benoist Girard,  PFU = Press-Fit Universal, THR = 
total hip replacement and HG II = Harris-Galante II.
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figure 10. Cox-adjusted survival curves of 19,859 total hip replacements in patients aged 55 years or older 
with total hip replacement design as the strata factor in study iii. The end point was defined as revision of 
the stem and/or the cup due to aseptic loosening. Adjustment was made for age and gender. Abbreviations; 
PCA = Porous Coated Anatomic, ABG = Anatomique Benoist Girard,  PFU = Press-Fit Universal, THr = 
total hip replacement and HG ii = Harris-Galante ii. 
9.1.3.3.2 Survival rate for any reason
When all patients aged 55 years or more were analysed as a single group, the 
survival rate at 15 years of the cementless designs was found to be lower than 
that of the reference group. Cox regression analysis revealed that during the first 
seven postoperative years the ABG I/ABGII had a significantly decreased risk of 
revision as compared to the cemented reference group (Table 27). Furthermore, 
the ABG II/ABG II combination was the only design which had an increased risk of 
revision during the first seven years after the primary operation (Table 27). Beyond 
seven years of follow-up, however, several cementless designs (the Anatomic Mesh/
HG-II, the PCA Standard/PCA Pegged, the ABG I/ABG I) showed higher risks of 
revision than the cemented reference group (Table 27, Figure 11), and none of the 
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cementless designs had a lower risk of revision than the reference group beyond 
seven years. The numbers of the ABG I/ABG II THRs found beyond seven years 
was scarce (Table 27).
During the first seven postoperative years the risk ratio for revision due to any 
reason of cementless THRs for the 55-64 year group did not differ significantly from 
that of the cemented reference group. Beyond seven years of follow-up, however, 
the revision risks of the Anatomic Mesh/HG-II (RR 1.59, CI 1.15-2.20), the PCA 
Std/PCA Pegged (RR 1.53, CI 1.12-2.09), the Bi-Metric/PFU (RR 1.48, CI 1.13-1.93), 
the Bi-Metric/Mallory (RR 1.98, CI 1.27-3.08) and the ABG I/ABG I (RR 3.23, CI 
2.26-4.63) were increased compared to the reference group. 
During the first seven years, the risk ratio for revision due to any reason for 
cementless THRs did not differ significantly for the 65-74 year group from that of 
the cemented reference group, except for the ABG I/ABG II, which had a decreased 
risk of revision compared to that of the reference group (RR 0.45, CI 0.28-0.72). 
Except for the PCA Std/PCA Pegged (RR 2.02, CI 1.27-3.28) design, which had an 
increased risk of revision compared to the reference group beyond seven years of 
follow-up, the risk ratio for revision due to any reason for cementless THRs did 
not differ significantly from that of the cemented reference group. 
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Figure 11. Cox-adjusted survival curves of 19,859 total hip replacements in patients aged 55 years 
or older with total hip replacement design as the strata factor in study III. The end point was 
defined as revision of the stem and/or the cup for any reason. Adjustment was made for age and 
gender. Abbreviations; PCA = Porous Coated Anatomic, ABG = Anatomique Benoist Girard, PFU 
= Press-Fit Universal, THR = total hip replacement and HG II = Harris-Galante II. 
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figure 11. Cox-adjusted survival curves of 19,859 total hip replacements in patients aged 55 years or older 
with total hip replacement design as the strata factor in study iii. The end point was defined as revision of 
the stem and/or the cup for any reason. Adjustment was made for age and ge der. Abbreviations; PCA 
= Porous Coated Anatomic, ABG = Anatomique Benoist Girard, PFU = Press-Fit Universal, THr = total hip 
replacement and HG ii = Harris-Galante ii.
9.2 hospitAl dischArge register-bAsed studies (iv And v)
9.2.1 reGional Variation in tha rates (stUdy iV)
Over the 1998 to 2005 period, 44 093 primary THAs were performed in Finland. Of 
these, 34 675 were performed due to primary OA (79% of all primary THAs) (Table 
28). The number of primary THAs for primary OA increased by 67 per cent over 
the eight year period (Table 28). In 2005 the incidence per 100 000 inhabitants 
of primary THAs for primary OA was 112 (Table 29). There was a tendency for 
the proportion of men to increase towards the end of the study period (Table 28).
There was considerable geographical variation in THA incidence rates. The 
relative differences in rate between the highest and lowest scoring region adjusted 
for age and for gender was threefold in 1998, 1.9-fold in 2005 and from two to 2.3-
fold in all other years studied (Table 29). 
The adjusted incidence index for the capital, Helsinki, was continually below 
the average for the whole country (Figure 12, Tables 30 and 31). 
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9.2.2 vAriAbles possibly AssociAted with regionAl vAriAtion of thA 
(study iv)
When the ratio of THAs performed for primary OA to THAs performed for any 
reason was high, the absolute incidence of THAs was high (p<0.001). Similarly, 
high need-adjusted expenses of specialized care (p<0.001) were also associated 
with a high incidence rate of THA for primary OA.
In contrast, a large proportion of patients aged between 18 to 64 years who had 
permanent disability pension because of orthopaedic disorders or connective tissue 
disease was associated with a low incidence rate of THA for primary OA (p<0.001).
None of the following factors were associated with the incidence rate of THA 
for primary OA: the relative number of orthopaedic surgeons or anesthesiologists, 
population density, average distance of inhabitants of the region to the nearest 
hospital performing THAs, the average incomes in a region as evaluated by state 
taxation and morbidity index. 
1998 1999 2000 2001 2002 2003 2004 2005
The number of all primary THAs 4538 4660 4984 5197 5755 6153 5859 6947
The number of primary THAs for 
primary OA 3421 3506 3878 4099 4517 4891 4643 5720
mean age (in years) 68.3 68.3 68.1 68.0 68.1 67.6 67.7 67.9
Gender (proportion of men, %) 40.2 42.2 42.5 42.4 41.5 43.8 44.9 44.9
table 28. The number of all primary THAs, the number of all primary THAs for primary OA, the mean age 
of the patients (in years) and the proportion of men of all patients (%) operated on in Finland over the 
1998-2005 period in study iV.
1998 1999 2000 2001 2002 2003 2004 2005
incidence in the whole country 67 69 76 80 89 96 91 112
The highest regional incidence 147 110 109 144 128 147 138 163
The lowest regional incidence 45 46 43 48 66 68 58 69
Adjusted incidence index in the 
whole country 100 101 110 114 124 133 124 150
The highest regional adjusted 
incidence index 219 160 156 169 176 200 184 190
The lowest regional adjusted 
incidence index 73 72 69 77 86 91 87 104
table 29. The unadjusted incidence of primary THAs for primary OA per 100 000 inhabitants for the 
whole country, including the highest and the lowest regional incidences and the age- and gender adjusted 
incidence indices of primary THAs for primary OA for the whole country, including the highest and the 
lowest regional adjusted incidence indices for the 1998-2005 period in study iV. 100 is taken as the average 
for the whole country in 1998 and thus 1998 is taken as the base year.
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Figure 12.  Districts, adjusted indices of regional incidence and 95% confidence intervals of the 
index, years 1998-2005 summed together in study IV. Adjusted indices were compared up to the 
level of the whole country in year 1998 (the whole country 1998-2005 = 100).  
figure 12.  Districts, adjusted indices of regional incidence and 95% confidence intervals of the index, years 
1998-2005 summed together in study iV. Adjusted indices were compared up to the level of the whole 
country in year 1998 (the whole country 1998-2005 = 100). 
1998 1999 2000 2001
district index 95% ci incid. index 95% ci incid index 95% ci incid. index 95% ci incid.
Varsinais-suomi 129 117-142 92.5 104 93-116 75.4 122 110-134 89 137 125-150 101.4
satakunta 117 101-134 87.7 117 102-134 89.5 119 104-136 93.2 125 110-142 100.2
Kanta-Häme 100 83-119 74.6 93 77-111 70.2 123 104-144 93.8 108 91-128 84
Pirkanmaa 93 82-104 65.3 105 94-117 74.4 108 97-120 77.5 107 96-119 77.3
Päijät-Häme 80 66-96 57.5 96 81-113 70.6 87 73-103 65.3 96 81-112 73.4
Kymenlaakso 73 60-89 56.7 94 79-111 73.9 127 110-147 102.2 132 114-152 108.1
etelä-Karjala 74 58-93 56.8 91 73-111 70.9 115 95-138 91 83 67-102 67.1
etelä-savo 91 72-113 73.2 120 98-145 97.9 128 106-154 106.9 169 143-198 144.4
itä-savo 118 92-151 99.1 112 86-143 95.7 121 94-153 106.3 139 110-173 124.5
Pohjois-Karjala 83 68-100 61.5 72 58-88 54.5 106 89-125 81.4 119 101-139 92.8
Pohjois-savo 141 125-159 102.8 120 105-137 89.3 130 114-147 98.1 143 127-161 110.3
Keski-suomi 110 95-126 77 111 96-127 78.5 117 103-134 84.3 120 105-136 87.4
etelä-Pohjanmaa 119 102-138 89.4 113 96-131 85.7 111 95-129 85.7 145 127-166 113.9
Vaasa 108 91-128 79.1 87 72-105 64.4 111 94-132 83.1 119 100-139 89.8
Keski-Pohjanmaa 219 181-263 146.9 160 128-198 109.5 156 125-193 108.8 146 116-181 104.3
Pohjois-Pohjanmaa 84 73-98 49.3 105 92-119 61.9 116 102-131 69 99 87-113 60.2
Kainuu 85 64-111 61.5 73 53-96 54.1 84 63-109 64.2 95 73-122 75.7
Länsi-Pohja 84 60-114 57.2 105 78-138 73.7 118 89-152 84.6 119 91-154 88.5
Lappi 98 77-121 64 112 91-137 75.9 136 113-163 95 126 104-152 91.4
Helsinki 73 64-82 45 74 65-83 45.7 69 61-79 43 77 68-87 48.4
Uusimaa 91 82-101 47.6 103 93-113 54.4 101 92-111 54.6 95 87-105 52.6
The whole country 100 97-103 67.4 101 98-104 69 110 107-114 76.2 114 110-117 80.2
table 30. Districts, adjusted indices of regional incidence (index), 95% confidence intervals (95% Ci) of the 
index and regional incidences per 100 000 inhabitants in 1998-2001 in study iV. Adjusted indices (index) 
were compared to the level of the whole country in year 1998 (the whole country 1998 = 100).
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2002 2003 2004 2005
district index 95% ci incid. index 95% ci incid index 95% ci incid. index 95% ci incid.
Varsinais-suomi 146 133-159 109.1 132 120-145 100.3 136 124-149 105.2 163 150-176 127
satakunta 114 99-131 93.1 147 130-165 121.8 120 105-136 101.5 170 152-189 146.7
Kanta-Häme 115 97-134 89.8 132 114-154 105 133 114-154 106.8 140 121-162 113.4
Pirkanmaa 116 105-128 84.7 134 122-147 98.8 139 127-152 103.7 163 150-177 122.3
Päijät-Häme 95 81-112 74.2 99 84-115 78.5 87 74-102 70.7 130 113-148 107.1
Kymenlaakso 130 113-150 107.9 139 121-159 117 138 120-158 118.2 172 152-194 149.9
etelä-Karjala 86 69-105 70.3 126 106-149 105.3 113 94-135 96.4 189 165-217 163.3
etelä-savo 123 102-148 107.5 143 120-169 127.1 166 140-196 151 172 146-200 158.2
itä-savo 109 84-139 100.4 100 76-129 93.4 95 72-123 90.9 160 130-195 155.8
Pohjois-Karjala 125 107-145 99.2 154 134-177 124.7 98 82-116 80.4 167 147-190 140
Pohjois-savo 137 121-155 107.2 156 139-174 123.3 140 124-157 112.7 190 171-209 155.6
Keski-suomi 138 122-155 101.6 147 131-165 110.2 124 109-140 94.1 142 126-159 109.8
etelä-Pohjanmaa 145 127-166 115.1 179 159-201 143.5 146 128-166 118.7 171 152-193 140.5
Vaasa 103 86-122 78.4 91 75-109 70.5 118 100-139 92.7 177 155-201 139.5
Keski-Pohjanmaa 176 143-214 127.8 200 165-240 147.3 184 151-223 138.4 163 132-199 123.9
Pohjois-Pohjanmaa 145 130-161 89.1 134 120-150 83.6 135 121-151 85.6 147 132-163 94.3
Kainuu 147 120-179 119.8 134 108-164 111.2 107 84-134 91.2 126 101-154 109.1
Länsi-Pohja 94 69-125 71.5 162 129-201 125.6 139 109-174 109.6 125 97-159 100.7
Lappi 141 118-168 105.3 156 131-183 119.2 132 110-157 103.5 143 120-169 114.9
Helsinki 112 101-123 70.9 105 95-117 67.8 89 79-99 58.1 104 94-115 68.8
Uusimaa 118 109-128 66.4 118 108-128 67.6 118 109-128 69.4 122 112-131 73
The whole country 124 121-128 88.8 133 129-136 96.1 124 120-157 91.3 150 146-153 111.9
table 31. Districts, adjusted indices of regional incidence (index), 95% confidence intervals (95% Ci) of the 
index and regional incidences per 100 000 inhabitants in 2002-2005 in study iV. Adjusted indices (index) 
were compared to the level of the whole country in year 1998 (the whole country 1998 = 100). 
9.2.3 los, luic And costs (study v)
LOS was significantly longer for Group 1 than for Group 4 (p=0.0001) and for Group 
3 (p=0.0006). However, the LOS was shorter for the Group 1 than for the Group 
2 (p=0.0001).  The mean annual LOS in hospital volume groups are presented in 
Table 32.
The LUIC was shorter for Group 4 than for Group 1 (p=0.0001). Nonetheless 
LUIC was longer for Group 3 (p=0.0001) and for Group 2 (p=0.0001) than for 
Group 1. The mean annual LUIC-LOS in hospital volume groups are presented in 
Table 33.
87
If all THRs of the study period in Finland had been performed in the very high 
volume hospitals with the shortest length of stay, theoretically 39 650 days would 
have been saved (1.41 days per patient) (Table 32). Thus, theoretically costs would 
have been decreased by 20 895 550 euros. The effect of difference in LUIC-LOS 
to saving days was minor (Table 33).
If all THRs of the study period in Finland had been performed in the very high 
volume hospitals, then this would have lead to a total of 583 extra re-admissions 
at 14 days. The increased cost resulting from these re-admissions would have been 
162 074 euros. 
If the putative increased costs due the higher number of re-admissions (162 074 
euros) were subtracted from the total savings for the LOS reduction (20 895 550 
euros), then the net savings during the follow-up time would be 20 733 476 euros.
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re-ads 
14 days
re-ads 
42 days
Dis-
locations
re-
operations infections
Groups Or
95% Wald 
Confidence 
Limits
Or
95% Wald 
Confidence 
Limits
Or
95% Wald 
Confidence 
Limits
Or
95% Wald 
Confidence 
Limits
Or
95% Wald 
Confidence 
Limits
2 vs 1 1.21 1.00-1.46 0.98 0.85-1.12 0.88 0.70-1.11 1.05 0.83-1.33 1.07 0.67-1.70
3vs 1 1.35 1.12-1.64 0.96 0.84-1.11 0.70 0.55-0.90 0.96 0.75-1.23 0.88 0.54-1.45
4 vs 1 1.43 1.18-1.74 1.17 1.02-1.36 1.09 0.85-1.41 0.94 0.72-1.23 0.80 0.48-1.35
table 34. Adjusted odds ratios for unscheduled re-admissions in 14 and in 42 days, dislocations, re-operations 
and infections in study V. Abbreviations: Or = odds ratio and re-ads = re-admissions. Group 1 = 1-50 (low 
volume hospitals), Group 2 = 51-150 (average volume hospitals), Group 3 = 151-300 (high volume hospitals) 
and Group 4 = 301 or over (very high volume hospitals) primary and revision knee and hip replacements 
performed annually.
9.2.4 unscheduled re-Admissions And complicAtions (study v) 
Adjusted odds ratios of hospital groups for unscheduled re-admissions at 14 and 
at 42 days, dislocations, re-operations and infections are presented in Table 34. 
There were significantly fewer re-admissions within 14 days for Group 1 than for 
all other hospital groups. There were significantly more dislocations for Group 1 
than for Group 3. Hospital volume was not associated with re-operation rates or 
with infection rates.
91
10. disCUssion
10.1 vAlidity of the dAtA
10.1.1 the finnish ArthroplAsty register-bAsed studies (i, ii And iii)
Register-based studies have certain limitations. Prior to 1994, 10 per cent of total 
hip replacements performed in Finland were missing from the Finnish Arthroplasty 
Register (Puolakka et al. 2001a). These THRs were lost to follow-up and could have 
been failures that would have caused bias in our study. It is also possible that few 
centres performed the majority of the replacements and certain complications could 
have occurred more often at certain centres. However, a single centre or an implant 
giving poor results does not have a major effect on the overall results in a register-
based study involving very high numbers. It is actually the purpose of register 
studies to evaluate population-based results for hospitals and implants of variable 
standards. A limitation of register-based studies is that only a revision operation 
per se is defined as a failure. There might be patients with polyethylene failure, 
osteolysis or loosened implants who are too ill to undergo revision surgery, or those 
who simply prefer not to do so, or other patients who are not even aware of having 
a problem associated with their implants. Furthermore, selection bias may occur, if 
some surgeons do not use cementless implants under certain circumstances. One 
such circumstance could be severe osteoporosis (study I and III). However, this kind 
of selection bias can in theory only be avoided by conducting a randomized controlled 
trial. Recently, it was stated that well designed observational studies provide reliable 
information on treatment effects, and that the role of single randomized controlled 
studies should not be overemphasized in clinical decisions (Benson and Hartz 2000, 
Concato et al. 2000).
In studies II and III, the implantation of different designs varied over the years 
(Tables 6 and 9, respectively). In some studies, modern cementing techniques have 
resulted in higher long-term survival (Herberts and Malchau 2000, Malchau et al. 
2002) compared to earlier techniques. However, this has not been verified in all 
studies (Puolakka et al. 2001a). In study III, some of the three cemented designs 
used as the reference group were implanted over the whole study period starting 
in 1980. Any recent developments in cementing techniques adopted may result in 
higher long-term survival rates for those prostheses, which were implanted later in 
the study period (Herberts and Malchau 2000, Malchau et al. 2002). Nevertheless, 
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the cemented implants chosen in study III were the best performing designs found 
in study II. 
In study III, the proportional hazards assumption of the Cox model (meaning 
that the relative difference between revision rates should be constant over the elapse 
of time since the primary operation) was not reached in some analyses performed. 
Therefore, adjusted risk ratios were also established within defined time intervals 
(0-7 years, >7 years after the primary operation). Follow-up beyond seven years 
revealed that the results regarding cementless cups, and therefore regarding 
cementless THRs, do deteriorate over time. 
10.1.2 hospitAl dischArge register-bAsed studies (iv And v)
The main strength of studies IV and V was the access to a nationwide database 
with previously documented high data validity that allowed a population-based 
approach for this study. The reliability of the Discharge Register for reporting 
surgical operations is high. As early as the late 1980’s at least 95 per cent of 
operations were recorded in the Discharge Register (Keskimäki and Aro 1991). The 
correlation between Nordic discharge registers and Nordic arthroplasty registers is 
high (Söderman et al. 2000, Pedersen et al. 2004, Arthursson et al. 2005, Peltola 
2008). It is also notable that the data of studies IV and V also include all private 
hospitals. Thus these data are comprehensive.
One limitation of the study IV was that no information on waiting times was 
available. The data in the Discharge Register in Finland regarding waiting times are 
considered incomplete (Järvelin and Linna 2004). Long waiting lists and a high rate 
of surgery can result from a high demand for surgery, which in turn is influenced 
by decisions taken by physicians (Nordberg et al. 1994). We had no information 
on the preference of patients or of physicians for surgery. Similarly we had no 
information about local guidelines for clinical decision-making, or the number of 
specialist nurses available. The method of extreme quotients in estimating variation 
is susceptible to potential skewing effect of outliers because it does not exclude the 
variance attributable to outlying random variation (Keskimäki et al. 1994). However, 
in a previous report on data obtained from the Finnish Discharge Register, it was 
concluded that the method of extreme quotient produces reliable results for THAs 
(Keskimäki et al. 1994).
Patient age, sex and surgical and medical diagnoses were adjusted in study V. 
Calculations were also performed using head size of the prosthesis in the adjustments 
to eliminate the effect of head size to dislocation rate. However, the data of head 
size of the prosthesis was missing in 1402 of all THRs studied (5%). The head size 
of 28 mm was used in 86 per cent of those THRs for which such information was 
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available. The effects of hospital volume on dislocation rates were very similar with 
or without adjustment of the head size. However, not all factors associated with 
dislocation rate, such as the surgical approach used, could be adjusted in study V. 
Data on the effect of surgeon’s volume on results of THR separate from the 
effect of hospital volume were not available in study V. However, it has already 
been reported that surgeon volume is a very good indicator of orthopaedic adverse 
events in THR surgery (Solomon et al. 2002). Surgeon volume in a single hospital is 
basically a question of organizational choice and capability of reasonable orthopaedic 
decision-making in that hospital. A limitation of our study is that a single hospital 
may have a major effect on results when there were only a few hospitals in a particular 
group. The length of the follow-up in the current study was short and we were not 
able to evaluate the relationship between hospital volume and long-term survival of 
replacements. Furthermore, we did not have data on the numbers of unscheduled 
visits to unspecialized public primary health care or to private physicians after THR. 
Telephone contacts were not recorded either. 
10.2 generAl discussion
10.2.1 the finnish ArthroplAsty register-bAsed studies (i, ii And iii)
10.2.1.1 Implant groups
Recent Scandinavian national register-based studies have shown excellent long-term 
survivorship for cemented THRs in patients with primary OA (Havelin et al. 2000, 
Malchau et al. 2002, Espehaug et al. 2009, Havelin et al. 2009). Survival of cemented 
implants was shown to be better than survival of cementless implants (Malchau 
et al. 2002). When our data were compared with those of other Nordic registries, 
the differences in survivorship between cementless and cemented implants in 
elderly patients are interesting. In Finland, the tradition of cementless total hip 
arthroplasty is strong. In Sweden and in Norway, the use of cementless implants 
has not been as common as in Finland (Herberts and Malchau 2000, Malchau et al. 
2002, Havelin et al. 2009). In our opinion, reports from the Swedish Arthroplasty 
Register have not taken into account substantial differences between cementless 
hip replacements, some of which have proved to have excellent (Archibeck et al. 
2001, Bojescul et al. 2003, Jacobsen et al. 2003, Marshall et al. 2004, Meding et al. 
2004, Oosterbos et al. 2004, Parvizi et al. 2004a, Eskelinen et al. 2005, Eskelinen et 
al. 2006) and others catastrophic (Engh et al. 1990, Tallroth et al. 1993, Simank et 
al. 1997) results. We think that the survival data of cementless implants should be 
analysed by implant groups and be presented as such. On the other hand, systematic 
instructions for cementing techniques and reporting of the results were started 
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very early in Sweden, which has certainly aided in achieving the high long-term 
survivorship of cemented replacements reported from the Swedish register. In study 
I, survivorship of cementless stems for aseptic loosening was superior to that of 
cemented stems for patients aged 55 to 74 years. To the best of our knowledge, this 
finding has not been reported previously. The results of the study I also suggest 
that the survivorship of cementless cups for aseptic loosening can be as good as 
those of the cemented types in elderly patients. However, a large number of wear-
related revisions of modular cementless cups are an alarming finding, which clearly 
emphasizes the need for more wear-resistant articulations for cementless cups. 
The problem or cup/liner incongruity of the two-piece acetabular designs with an 
incomplete locking mechanism was emphasized in study I. This problem was due 
to the large proportion of those cups designs that have been reported to have a 
high incidence of liner problems.
10.2.1.2 Cemented THA
10.2.1.2.1 The Charnley prosthesis
In study II, results of the Charnley prosthesis were not as good as those in other 
studies (Berry et al. 2002, Wroblewski et al. 2002, Buckwalter et al. 2006, Espehaug 
et al. 2009). Only the Elite Plus prosthesis, which is a modification of the Charnley 
prosthesis, had a poorer outcome than the Charnley prosthesis. However, the 
number of Charnley prostheses implanted in Finland was small (925) compared 
to the Exeter Universal/ Exeter All-poly prosthesis (5,048). There may be a bias 
concerning the centre in which the operations took place. The Charnley prosthesis 
may also have been affected by the cohort. The use of the Exeter Universal/ Exeter 
All-poly prosthesis in Finland was started nine years later than the use of the 
Charnley prosthesis. Furthermore, when we analysed the 12 most common THR 
designs, only those Charnley stems that were implanted together with the LPW 
(=long posterior wall) cup were included. Combinations with other cups such as 
the Charnley Standard were not included, because these were not among the 12 
most common replacements used in Finland. The LPW socket can generate twice as 
much torque as the standard socket and therefore is more likely to loosen (Murray 
1992). The poor results of the cup component may have had a detrimental effect 
on the results of the Charnley stem.  
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10.2.1.2.2 The Lubinus prosthesis
The Lubinus prosthesis has been used widely in Finland, Sweden and Norway 
(Puolakka et al. 2001, Malchau et al. 2002, Espehaug et al. 2009). However, long-
term survival rates of the Lubinus prosthesis have been contradictory (Partio et al. 
1994, Alho et al. 2000, Havelin et al. 2000, Puolakka et al. 2001a, Malchau et al. 
2002, Espehaug et al. 2009). In study II, survival of the Lubinus replacements were 
not as good as those of the best-performing designs. For any reason, the 10-year 
survival rate of the Lubinus SP II/ Lubinus IP prosthesis for patients aged 55 to 
64 years was 88 per cent, but at 15-years it had declined to only 73 per cent. This 
finding emphasizes the importance of continual surveillance and reporting beyond 
10-years of follow-up.
10.2.1.2.3 The Exeter prosthesis
In study II, the overall survival of the matte-finished Exeter stem combined with the 
metal-backed cemented cup was poor. The overall survival of the Exeter Universal/
Exeter All-poly was good. These results are in accordance with previous reports 
(Howie et al. 1998, Malchau et al. 2002, Williams et al. 2002, Hook et al. 2006, 
Carrington et al. 2009, Espehaug et al. 2009). 
10.2.1.2.4 The Müller prosthesis
In study II, the survivorship of the Müller prosthesis was good regarding those 
patients who were older than 64 years. Good long-term results for the Müller stem 
have also been published previously (Räber et al. 2001, Riede et al. 2007, Clauss 
et al. 2009). 
10.2.1.2.5 The Elite Plus prosthesis
The survival of the Elite Plus prosthesis was found to be poor in study II. Reports of 
the poor performance of the Elite Plus prosthesis have also been published previously 
(Walton et al. 2005, Hauptfleisch et al. 2006). Changes to the Elite Plus stem but 
not to the Charnley stem included: a modification of the shoulder flange designed 
to reduce subsidence (Wroblewski et al. 1998), an altered surface finish, improved 
material, and new instrumentation (Elite Plus Total Hip System). Furthermore, 
catastrophic failures of the Elite Plus prosthesis with the Hylamer acetabulum and 
zirconia ceramic femoral head have been reported (Norton et al. 2002). However, 
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the all-poly Hylamer cups have not been used in Finland. There seems to be no 
reason to continue performing Elite Plus replacements. 
10.2.1.2.6 The Spectron EF/the Reflection All-poly
The combination of the Spectron EF stem and the Reflection All-poly cup has 
become very popular in Finland, despite the fact that long-term results for this 
design have not yet become available. In study II, the short-term results for this 
design were promising. This is in accordance with previous data for the older version 
of the stem, the satin Spectron stem (Garellick et al. 1999, Malchau et al. 2002, 
Kale et al. 2003). A modified version of the Spectron stem, the Spectron EF, was 
introduced in 1989 with the addition of a distal centraliser, head modularity, and 
a rough surface finish in the proximal third (Grose et al. 2006). In Finland, only 
the roughened version has been used. High failure rates of the Spectron EF stem 
have recently been published (Gonzales Della Valle et al. 2006, Grose et al. 2006). 
Nevertheless, this aseptic failure, which is characterized by debonding, subsidence, 
and metallic shedding with femoral osteolysis and metallosis, has not been reported 
for the satin finish Spectron stem (Gonzales Della Valle et al. 2006). In a study 
based on data from the Norwegian Arthroplasty Register, it was stated that beyond 
five years follow-up, the Reflection All-Poly cup had a 14 times higher revision rate 
than the Charnley cup. Moreover, the Spectron EF stem had higher revision rate 
due to aseptic loosening than the Charnley stem, RR = 6.1 (Espehaug et al. 2009). 
Time will tell if there is difference in survival of the satin finished Spectron stem 
and the Spectron EF stem. It is interesting to see, if the good results in the current 
study in the short term will remain in longer term, or shall there be more aseptic 
loosenings as suggested in above mentioned studies. 
In study II, the survival of cemented prostheses for the age groups of 55 to 64 
years and 64 to 74 years was not excellent. However, almost all cemented designs 
performed well for the age group of 75 years and older. In study I it was found 
that cemented prostheses have higher risks of revision for aseptic loosening than 
their cementless counterparts for patients aged 55 to 74 years with OA. The causes 
of these relatively poor survival rates of cemented designs in Finland are unclear. 
Hip replacements have been performed in numerous low-volume hospitals in 
Finland until recently. Furthermore, third-generation cementing techniques may 
not have been widely adopted among Finnish orthopaedic surgeons during the 
1990s. Moreover, cementing techniques have only been categorically documented 
in the Finnish Register since 1996. 
In study I, composite-beam stems (Shen 1998, Scheerlinck and Casteleyn 2006) 
were found to have a significantly increased risk of revision for aseptic loosening 
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compared to the loaded-taper stems (Ong et al. 2002, Scheerlinck and Casteleyn 
2006). The Exeter Universal stem, which is a loaded-taper stem, also had a good 
survival in individuals of the youngest age-group in study II. It cannot be categorically 
stated that the survival of cemented prostheses in Finland is poor. However, the 
long-term survival of cemented composite-beam stems was found to be poor, and 
the survival of cemented all-poly cups was not excellent either. 
10.2.1.3 Cementless THA
10.2.1.3.1 The Biomet prostheses
Survival rates of 95 to 100 per cent for follow-ups of between five to 15 years have 
been reported for the Bi-Metric stem (Jacobsen et al. 2003, Marshall et al. 2004, 
Eskelinen et al. 2006). In study III, we found a higher survival rate for aseptic 
loosening of the Bi-Metric stem than that of the reference stems in patients aged 55 to 
74 years. When revisions for aseptic loosening were analysed, the Press-Fit Universal 
cup was found to have a comparable survival rate to those of the reference cups in 
patients aged 55 to 74 years. In Finland, Biomet cups were used with Hexloc liners 
until 1995 and have been used with Ringloc liners since then. In an earlier study 
based on data from the Finnish Register, survivorship of the Press-Fit Universal 
cups with Hexloc-liners was poor (Puolakka et al. 1999).  Reasons for increased 
wear of Hexloc liners were thin polyethylene, poor quality of the polyethylene, the 
cylindrical design and a poor locking mechanism (Puolakka et al. 1999, Puolakka et 
al. 2001b). Furthermore, screw-holes of Press-Fit Universal cups were unplugged. 
In the present study, the survival rate of the Bi-Metric/Press-Fit Universal at 15 
years was lower than that of the cemented reference group when all revisions were 
taken into account. However, the adjusted risk of revision for any reason for the Bi-
Metric/Press-Fit Universal was similar to that of the reference group. This finding 
is probably influenced by the positive impact of Ringloc liners (beginning 1995) 
on results of the Bi-Metric/Press-Fit Universal. Unfortunately, it is not possible to 
analyse the survival rate of the Press-Fit Universal cups with Hexloc liners separately 
from the Ringloc liners in the Finnish Register data. Revision risk of the Bi-Metric/
Vision for any reason was similar to that of the cemented reference group (Table 
27, Figure 11). However, survival rates at 10-years of the Vision cup with Ringloc 
liners and plugged screw-holes are not yet available. 
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10.2.1.3.2 The Anatomic Mesh/Harris-Galante II
Survival rates at 10 years ranging from 96 to 99 per cent have been reported for 
the Harris-Galante II cup (Archibeck et al. 2001, Firestone et al. 2007, Surdam 
et al. 2007,) and 100 per cent survival rates for the Anatomic stem (Archibeck 
et al. 2001), respectively. In study III, the survival rate for aseptic loosening of 
the Anatomic Mesh/Harris-Galante II at 15 years did not differ from that of the 
cemented reference group. Nonetheless, the survival rate for any reason of the 
Anatomic Mesh/HG-II at 15 years was poor. Again, this finding can be attributed 
to wear-related factors. The Anatomic Mesh/Harris-Galante II is no longer being 
implanted into patients in Finland.
10.2.1.3.3 The PCA prosthesis
Mid- to long-term survival rates ranging from 91 to 97 per cent of the PCA Standard 
stem have previously been reported (Thanner et al. 1999, Xenos et al. 1999, Bojescul 
et al. 2003, Moskal et al. 2004, Kim 2005). The 15-year survival rate of the PCA 
Standard stem in study III was comparable to that reported earlier, but lower than 
those of the best-performing stems. Survival rates ranging from 85 to 94 per cent 
for seven to 13 years (Malchau et al. 1997, Thanner et al. 1999, Xenos et al. 1999, 
Moskal et al. 2004) and from 79 to 83 per cent for 15 to 20 years (Bojescul et al. 
2003, Kim 2005) have been published for the PCA Pegged cup with high revision 
rates associated with osteolysis. In the current study, the survival rate of the PCA 
Pegged cup at 15 years was poor. The PCA Standard/PCA Pegged prosthesis is no 
longer being implanted into patients in Finland.
10.2.1.3.4 The ABG prosthesis
Survival rates of the ABG I/ABG I arthroplasty have been reported to range from 92 
to 100 per cent between two to 13 years (Giannikas et al. 2002, Herrera et al. 2004, 
Oosterbos et al. 2004, Castoldi et al. 2007), though the incidence of polyethylene 
wear is alarming (Duffy et al. 2004). In study III, the survival rate for any reason of 
the ABG I/ABG I at 10 years was lower than that of the reference group. However, 
the survival rate of the ABG I stem at 10 years for aseptic loosening was higher 
than that of the reference group. For this reason and because of the poor liners of 
the ABG I cup design, in Finland the ABG I stem has been widely used along with 
the ABG II cup with plugged screw-holes and thicker Duration liners consisting of 
stabilised polyethylene (Stryker, Mahwah, NJ). In our study, the risk of revision for 
any reason of the ABG I/ABG II in patients aged 65 to 74 was lower than that of 
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the reference group when all revisions were taken into account. However, survival 
rates of the ABG I/ABG II at 10 years are not yet available. Survivorship of modular 
cementless cups may dramatically worsen after seven to 10 years of follow-up due 
to excessive wear and osteolysis, as indicated by the beyond seven year survival 
analysis of study III. Thus, it is too early to draw any reliable conclusions about 
the long-term success of this hip implant.
The ABG II stem differs from the ABG I stem with regard to its composition of 
titanium alloy, stem geometry, macrotexture, conus size and an option for zirkonia 
heads (ABG II Cement Free Hip System). The risk of revision for any reason of 
the ABG II/ABG II was higher than that of the reference group. The mean follow-
up time of the ABG II/ABG II design was short, only 2.5 years (Table 9). The 
proportion of periprothetic fractures of all revisions for the ABG II/ABG II was 
high, at 37 per cent (Table 11). This finding is in accordance with clinical experience 
in Finland. The ABG II stem seems to be vulnerable to perioperative periprothetic 
femoral fractures due to its anatomical and conical shape. There were only three 
aseptic loosenings of the ABG II stem found during the study period (Table 11). The 
problem with an early aseptic loosening of a cementless stem is that there may not 
have been any osteointegration at all at the beginning due to undersizing or other 
technical failure. Therefore, strictly speaking any associated loosening could not have 
happened either. A longer follow-up time is needed to see, whether either the ABG 
I/ABG II or the ABG II/ABG II provide a long-term solution to the wear problem. 
Only a few zirkonia head or liner fractures have been reported in Finland (Table 11).
10.2.1.3.5 Patients aged 75 years or older
In study III the survival rates for patients aged 75 years and older were similar 
between cementless implants and the cemented reference group, except that the PCA 
Pegged cup had an increased risk of revision compared to the cemented reference 
group. This is in accordance with results of study I. However, in another recent 
report from the Finnish Arthroplasty Register (Ogino et al. 2008) it was concluded 
that hybrid fixation (a cemented stem with a cementless cup) was significantly 
better than cementless fixation in patients 80 years of age and older. In study I, we 
concluded that the survival of the hybrid total hip for any reason for patients aged 75 
years and older was not significantly different from that of cemented or cementless 
groups. Even so, we think that these two findings on hybrid hip implantations 
in elderly patients based on data from the Finnish Arthroplasty Register are not 
contradictory. In the study by Ogino et al., 100 stems and 101 cups were used in 393 
combinations. The most commonly used stems were the Exeter Universal and the 
Lubinus SP II and the most commonly used cups were the Lubinus STD, the Exeter 
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All-Poly and the Exeter Contemporary, all of which are cemented implants. The 
cementless designs were not specified. In contrast, in study I we analysed survival 
rates of implant groups consisting of designs that had been used in more than 50 
operations during the study period. Implants associated with well-documented poor 
results and implants that did not belong to any of the groups of interest were excluded 
from that study. Thus, the data analysed in those two studies were remarkably 
different. In register-based studies it is extremely important to scrutinize closely 
the inclusion and exclusion criteria. In the current study, survival rates of the eight 
most common total hip replacements in elderly patients in Finland were analysed 
separately. However, the number of cementless implants in patients aged 75 years 
and older is low compared to the number of cemented implants. Therefore, one 
should be careful in drawing conclusions from such low numbers. 
10.2.2 hospitAl dischArge register-bAsed studies (iv And v)
10.2.2.1 Regional variation in THA rates
In Denmark the ratio for variation in THA was 1.4 between counties (Pedersen et 
al. 2005). The ratio of the highest to lowest regional rate for THAs was 4.7-fold 
in the Medicare population in the USA (Birkmeyer et al. 1998). In England, the 
rate of THA implantation varied between 25 to 30 per cent (Dixon et al. 2006). In 
a previous study on data obtained from the Finnish Hospital Discharge Register, 
the variation in the incidence of THA was threefold (Keskimäki et al. 1994). The 
1.9- to threefold difference in the incidence of THA in study IV was lower than 
that reported previously from Finland but higher than those reported for other 
European countries.  
10.2.2.2 Variables associated with regional variation of THA
10.2.2.2.1 Surgeon density and population density
In study IV, variations in relative orthopaedic surgeon or anesthesiologist numbers 
were not associated with THA incidence rates. Results from previous studies of 
surgeon or population densities have been contradictory (Peterson et al. 1992, 
Pedersen et al. 2005, Dixon et al. 2006). Despite the sparsely distributed population 
in Finland, the population density or the average distance of the inhabitants to the 
nearest hospital providing THAs were not associated with any regional variation in 
the current study. However, the incidence of THA in Helsinki was low. Accordingly, 
the incidence rate has also been reported to be low in other large cities including 
London, Copenhagen, Stockholm, Gothenburg and Malmö (Söderman et al. 2000, 
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Pedersen et al. 2005, Dixon et al. 2006). THAs are most often performed on the 
elderly. Good infrastructure with services and efficient public transport systems 
may help elderly patients to manage for longer in these very large cities. However, 
the data in study IV was age adjusted accordingly. It is also likely that occupational 
needs are different in urban areas and that one can manage for longer without a 
THA in urban than if one lived in a rural area.
10.2.2.2.2 The ratio of primary THA for primary OA to primary THA for any reason
In contrast to our findings, the proportion of patients with primary OA in Denmark 
was not associated with the variation in the THA rate (Pedersen et al. 2005). It 
is important to note that no regional variation in the prevalence of clinical hip 
OA between different parts of Finland has been shown to exist (Heliövaara et al. 
1993a, Baseline results of the Health 2000 examination survey). In Finland there 
are 20 hospital districts responsible for the management of hip surgery. However, 
in study IV the data are given for 21 hospital districts, not 20. This is because of its 
size Helsinki and its greater metropolitan area, Uusimaa, were counted as two and 
presented separately. The effect of the surgeon enthusiasm as an explanatory factor 
for area variation in arthroplasty (Chassin 1993, Wright et al. 1999) may become 
significant, if there are only a few surgeons responsible for performing THAs.
10.2.2.2.3 The need-adjusted expenses of specialized care
It has been estimated that the relative need of services has remained quite stable 
between the municipalities and regions in Finland over the period from 1993 to 
2004 (Hujanen et al. 2006). The difference in the need-adjusted expenses ratio 
between the most and the least expensive municipality has been reported to be 
2.5-fold (Hujanen et al. 2006). The need-adjusted expenses of specialized care have 
increased rapidly in the beginning of this century. Therefore, we wanted to find 
whether these increasing expenses were associated with the variation of regional 
THA incidence. In study IV, the high need-adjusted expenses of specialized care of 
a district were significantly associated with a high incidence of THAs. More money 
per capita “than needed” is spent in specialized care in districts where need-adjusted 
expenses are high. It is likely that some of this money is used to perform a high 
rate of THAs. When there are numerous small districts investing variable amounts 
in different forms of care, the risk of high regional variation of treatments would 
be expected to increase. 
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10.2.2.2.4 Proportion of working-aged patients having permanent disability 
pension because of orthopedic disorders
A high proportion of patients aged between 18 and 64 years who have permanent 
disability pension because of orthopaedic disorders was associated with a lower 
incidence of THA. It is likely that those with a permanent disability pension also have 
multiple orthopaedic disorders. Consequently, the willingness to perform a THA 
on such individuals is less, than it is for those with a single orthopaedic disorder, 
as the expected benefit from the procedure per se is also less. 
10.2.2.2.5 Relative number of long-term illnesses
Similar to our findings in study IV, Dixon et al. (2006) found that the number of 
limiting long-term illnesses and standardized mortality rates in a region providing 
THAs were not associated with the actual incidence of THAs in that region. A 
limitation of the morbidity-index used in study IV is that it was not possible to 
divide it into parts.
10.2.2.2.6 Socio-economic status
An association between incidences of THA and socio-economic status was found in 
both England and in Finland (Keskimäki et al. 1996, Dixon et al. 2004, Milner et 
al. 2004). In more recent studies, however, this association has not been detected 
(Pedersen et al. 2005, Dixon et al. 2006). In study IV, the average incomes in a 
hospital district were not correlated with the incidence of THA. However, socio-
economic status of the patient has been associated with arthroplasty rates in USA 
(Mahomed et al. 2003, Skinner et al. 2003). We are not aware of any reports of this 
subject from developing countries, but one might assume that such an association 
would be strong in these countries. We think that our results can influence THA 
rates emanating from developed countries by stating that socio-economic status 
of the patient does not limit patients access to THA. In developing countries and 
developed countries with large heterogenous populations socio-economic factors 
are probably of very high importance. 
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10.2.2.3 The association of hospital volume with results of THA
10.2.2.3.1 LOS and costs
In study V, very high hospital volume was associated not only with shorter surgical 
treatment periods but also with shorter uninterrupted institutional care. If all THRs 
during the study period were performed in the very high volume hospitals in Finland, 
743 euros/953 US dollars per patient could have been saved. However, when the 
post-operative care is made more effective, the easiest and cheapest days are dropped 
off, not the most demanding days, which include the first post-operative day and 
the discharge day. Costs will not be reduced, if the turnover of hospital wards does 
not increase and/or the number of personal decrease. In the near future in Finland, 
the baby boom generation, born in the late 40’s and early 50’s, will retire. Because 
of the demographically aging population and decreasing numbers of nurses, more 
patients will have to be treated in the future with the same levels of resources as 
that allocated today by optimizing activities and also the use of assets. 
10.2.2.3.2 Unscheduled re-admissions
In study V, the rate of re-admissions in the low volume hospitals was lower than in 
all other hospital groups. When the LOS is longer, early problems manifest in the 
hospital and are treated immediately in situ, thus re-admissions are less likely to 
occur than in shorter stay facilities. The costs of re-admissions were low compared 
to the costs of longer LOS.
10.2.2.3.3 Dislocations
In study V, the low volume hospitals had significantly higher dislocation rates than 
the high volume hospital groups. However, the dislocation rate of the very highest 
volume hospital (group 4) was not lower than that of the low volume hospitals 
(group 1). Very high volume hospitals are mainly university hospitals with junior 
surgeons performing replacements as part of their training. Furthermore, not all 
conditions such as obesity and alcoholism or the condition of the bone and soft 
tissues can be adjusted and it is likely that even after adjustments there are more 
demanding patients to be found in university hospitals that would have an adverse 
effect on dislocation rates. On the other hand, only a few surgeons may also have an 
impact on the results of a high volume unit when encountering problems with rare 
complications. Thus the importance of recording surgeon volume besides hospital 
volume is obvious.
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The number of private hospitals in the low volume hospitals (Group 1) was high 
(Table 14). The high dislocation rate in these low volume hospitals is worrisome, 
because THAs in small private hospitals are performed by specialists only. To the 
best of our knowledge, the current study is the first in which the association between 
high dislocation rates and low volume hospitals consisting of considerable numbers 
of small private hospitals has been found and reported.   
10.2.2.3.4 Infections
Nowadays, deep prosthetic infections after THR are rare and the capability of 
population-based studies to determine significant differences between hospitals is 
limited. In study V, patient age, gender, surgical and medical diagnoses factors were 
adjusted. Thus, it was not surprising that there was no association found between 
the infection rate and hospital volume.
10.2.2.3.5 Re-operations
Because the follow-up time in study V was short, it was assumed that many re-
operations were performed because of infections and instability. Early dislocations 
after THR are most often treated by closed reduction, which were analysed 
separately. Open reductions and revision operations as treatments for dislocated 
hip prosthesis are rare. The influence of open reductions and early revisions on 
the re-operation rate between hospital volume groups, if any, was not detected in 
study V. It seems that the variations in outcome of THAs are more closely linked 
to surgeon volume than to hospital volume, whereas the use of resources (costs) is 
more closely related to hospital volume. 
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11. ConClUsions 
1. For patients who were 55 years of age and older, the long-term survival of 
cementless total hip replacements was as good as that of cemented replacements. 
For patients who were 55 to 74 years old, straight porous-coated cementless 
stems had better long-term survival than the cemented stems. For patients 
who were 75 years of age and older, there were no significant differences in 
the results. Multiple wear-related revisions of the cementless cups indicate 
that excessive polyethylene wear was a major clinical problem with modular 
cementless cups for all age groups. 
2. There were considerable differences in the long-term survival of cemented stems 
in patients aged 55 years and older on a nation-wide level. The Exeter Universal/
Exeter All-poly had the best long-term outcomes of cemented replacements 
in Finland. However, none of the cemented prostheses provided the youngest 
age group of patients with excellent long-term survival. All cemented designs 
produced a reliable outcome in patients older than 74 years.
3. Cementless proximal porous-coated stems are a good option for patients aged 
55 years and older. Even though biological fixation of the prosthesis is a reliable 
implantation method for THA, polyethylene wear and osteolysis remain a 
serious problem for cementless cups.  
4. When hip surgery was performed on with a large repertoire, the indications 
to perform THAs due to primary OA were tight. Socio-economic status of the 
patient had no apparent effect on the THA rate. 
5. The specialization of hip replacements in high volume hospitals should 
reduce costs by significantly shortening the length of stay, and may reduce the 
dislocation rate.
Personal Conclusions 
Cementless fixation is more durable against aseptic loosening than cement fixation in 
THA patiets aged 55 years and older. Alternative bearings like ceramic-on-ceramic, 
metal-on-metal and highly cross-linked polyethylene bearings may help to reduce 
osteolysis and wear. However, for a single patient each re-operation – including a 
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liner-exchange - is a major incident. Therefore, revisions for all reasons should be 
emphasized in survival analyses. Surgeon decision-making related factors influence 
THA rates when there were only a few surgeons responsible for performing THAs in 
a particular region. According to the existing known literature, elective THAs should 
be performed at high volume centres in order to reduce mortality and complication 
rates.  
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